<SEC-DOCUMENT>0001140361-21-008995.txt : 20210318
<SEC-HEADER>0001140361-21-008995.hdr.sgml : 20210318
<ACCEPTANCE-DATETIME>20210318082357
ACCESSION NUMBER:		0001140361-21-008995
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20210318
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210318
DATE AS OF CHANGE:		20210318

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tronox Holdings plc
		CENTRAL INDEX KEY:			0001530804
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL INORGANIC CHEMICALS [2810]
		IRS NUMBER:				981467236
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35573
		FILM NUMBER:		21753166

	BUSINESS ADDRESS:	
		STREET 1:		263 TRESSER BLVD., SUITE 1100
		CITY:			STAMFORD
		STATE:			CT
		ZIP:			06901
		BUSINESS PHONE:		(203) 705-3800

	MAIL ADDRESS:	
		STREET 1:		263 TRESSER BLVD., SUITE 1100
		CITY:			STAMFORD
		STATE:			CT
		ZIP:			06901

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tronox Ltd
		DATE OF NAME CHANGE:	20110921
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10021910_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:trox="http://tronox.com/20210318" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_a7c5d9e596674a0bbeceba9cfe2cc7db" contextRef="c20210318to20210318" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_59ac52a45a6642d3a746fc04cc81114a" contextRef="c20210318to20210318">Tronox Holdings plc</ix:nonNumeric><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_8cca3f4e583a41edb115f36e868cb375" contextRef="c20210318to20210318">X0</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_49dae5e41193474ab699073fc646adef" contextRef="c20210318to20210318">0001530804</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="trox-20210318.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20210318to20210318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001530804</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-18</xbrli:startDate><xbrli:endDate>2021-03-18</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

  <div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

    <br />
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 10%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_a01eb2db74364d6ba3687cac0654a9c9" contextRef="c20210318to20210318">8-K</ix:nonNumeric></div>

    <div><br />
    </div>

    <div>
      <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 10%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported) March 18, 2021 (<ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_9ff6b029ea98487b8c18e002e91d9317" contextRef="c20210318to20210318" format="ixt:datemonthdayyearen">March 18, 2021</ix:nonNumeric>)</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>

    <div>
      <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 10%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_59ac52a45a6642d3a746fc04cc81114a">TRONOX HOLDINGS PLC</span><br />
    </div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact Name of Registrant as Specified in Its Charter)</div>

    <div><br />
    </div>

    <div>
      <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 10%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zfe57e753a9c24b219affe3814df37b75">


  <tr>

    <td style="width: 33.34%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_8cca3f4e583a41edb115f36e868cb375">England and Wales</span><br />
            </div>
          </td>

    <td style="width: 34%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_b5f5bd7261e343fe89be96653fad3861" contextRef="c20210318to20210318">001-35573</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 32.66%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_7e4ba92d73d341e5a9d4cc17ffa464da" contextRef="c20210318to20210318">98-1467236</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 33.34%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(State or Other Jurisdiction of Incorporation)</div>
          </td>

    <td style="width: 34%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Commission File Number)</div>
          </td>

    <td style="width: 32.66%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(IRS Employer Identification No.)</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9bda10f5d5de4aee98e6d51b87236e9e">


  <tr>

    <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_7021556e67f7443180beea2f02229f3b" contextRef="c20210318to20210318">263 Tresser Blvd., Suite 1100</ix:nonNumeric><br />
            </div>
          </td>

    <td colspan="1" style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 49%; vertical-align: middle;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Laporte Road, Stallingborough</div>
          </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_6844bdfef2ec482d8e788ab1d18a000b" contextRef="c20210318to20210318">Stamford</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_ab672749c7e7497592617e19bcd43a0e" contextRef="c20210318to20210318" format="ixt-sec:stateprovnameen">Connecticut</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_55ab067ecb804b6199df6dbbdca09369" contextRef="c20210318to20210318">06901</ix:nonNumeric></div>
          </td>

    <td colspan="1" style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 49%; vertical-align: middle;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Grimsby, North East Lincolnshire, DN40 2PR, UK</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Address of Principal Executive Offices) (Zip Code)</div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_b546b7da9e4f4781af3a7d48f8e09033" contextRef="c20210318to20210318">203</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_e020b9059b004fee8e86afd97df11b41" contextRef="c20210318to20210318">705-3800</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Registrant&#8217;s Telephone Number, Including Area Code)</div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Not Applicable</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Former Name or Former Address, if Changed Since Last Report)</div>

    <div><br />
    </div>

    <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 10%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;" />
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
      following provisions:</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbedb220baedc42d7b6d274f4aa70381e">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_e6cba4bb88ae4c949bfd1e2243953618" contextRef="c20210318to20210318" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z51a8f752175f40569ca2e923083e43d1">


  <tr>

    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_5cb80e84a1274c3fade1f7a8d0f32641" contextRef="c20210318to20210318" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4be2593b053643c0afcaebcecb3c841c">


  <tr>

    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_99a630e628234393934dd7b075bd8b92" contextRef="c20210318to20210318" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zafbb15a92b524b498a749d2f04e2a53e">


  <tr>

    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_8627eae0a96440b7999059d5c9e1e0ea" contextRef="c20210318to20210318" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z55cc485375be45e9a817854746a56635">


  <tr>

    <td style="width: 32.99%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Title of each class</div>
          </td>

    <td style="width: 34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Trading Symbol(s)</div>
          </td>

    <td style="width: 33%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Name of exchange on which registered</div>
          </td>

  </tr>

  <tr>

    <td style="width: 32.99%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_4b873e43b1284f76b718ff313f54165e" contextRef="c20210318to20210318">Ordinary shares, par value $0.01 per share</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_7916656328654921bb6239f8afba8b65" contextRef="c20210318to20210318">TROX</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_982751ad610e4121901153c56a9cbed6" contextRef="c20210318to20210318">NYSE</ix:nonNumeric><br />
            </div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Sec.230.405 of this chapter) or Rule 12b-2
      of the Securities Exchange Act of 1934 (Sec.240.12b-2 of this chapter).</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company&#160; <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_3bbf92582e6c4d98930ee95636041436" contextRef="c20210318to20210318" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
      financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; &#9744;</div>

    <div style="text-align: left;"><br />
    </div>

    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="page-break-after:always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0a24d1ed126242c8bcb57e32c1ddaca7">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.02.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">As discussed in the Current Report on Form 8-K filed by Tronox Holdings plc (the &#8220;Company&#8221;) with the Securities and Exchange Commission (&#8220;SEC&#8221;) on December 28, 2020,
      Chairman and Chief Executive Officer Jeffry N. Quinn began a leave of absence on December 27, 2020. On that date, the Company appointed John D. Romano, Executive Vice President, Chief Commercial and Strategy Officer, and Jean-Fran&#231;ois Turgeon,
      Executive Vice President and Chief Operating Officer, as co-Chief Executive Officers (each, a &#8220;co-CEO&#8221;) on an interim basis. In addition, on that date, the Company appointed Mr. Ilan Kaufthal, formerly the Company&#8217;s Lead Independent Director, as the
      Company&#8217;s Chairman of the Board of Directors (the &#8220;Board&#8221;) on an interim basis.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On March 18, 2021, the Company announced that pursuant to the Retirement Agreement between Mr. Quinn and the Company dated March 18, 2021 (the &#8220;Retirement Agreement&#8221;), Mr.
      Quinn had retired as Chairman of the Board and Chief Executive Officer of the Company and is no longer a member of the Board, all effective immediately. On March 18, 2021, the Company appointed Mr. Romano and Mr. Turgeon as co-CEOs on a permanent
      basis. On that date, the Board also increased the number of seats on the Board to ten, and elected Mr. Romano and Mr. Turgeon as directors of the Company. In addition, on that date, Ilan Kaufthal was elected Chairman of the Board on a permanent
      basis. As Chairman of the Board, Mr. Kaufthal is entitled to an additional annual retainer of $120,000.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Summaries of Mr. Romano&#8217;s and Mr. Turgeon&#8217;s biographical and business experience can be found
        in the Company&#8217;s Definitive Proxy Statement filed with SEC on April 27, 2020 on page 36, which summaries are incorporated by reference in this Item 5.02. There are no arrangements between either Mr. </span>Romano <span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">or Mr. Turgeon and any other persons, pursuant to which either Mr. </span>Romano <span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">or Mr. Turgeon was selected as a
        director. There are no related party transactions between the Company and either Mr. </span>Romano <span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">or Mr. Turgeon that would be required to be reported pursuant to
        Item 404(a) of Regulation S-K under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). </span>Mr. Romano and Mr. Turgeon will not receive any additional compensation for their service on the Board.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Retirement Agreement of Mr. Quinn</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the Retirement Agreement and generally consistent with his employment agreement and the Company&#8217;s past retirement practices, Mr. Quinn shall be entitled to
      receive: (1) a 2020 annual incentive plan bonus of $2,062,500, from which certain agreed expenses will be deducted; (2) the vesting of restricted stock units (&#8220;RSUs&#8221;) that were scheduled to vest in February and March 2021, more specifically: (a)
      30,239 time-based RSUs and 36,014 performance-based RSUs that were granted to him on February 8, 2018; (b) 68,748 time-based RSUs that were granted to him on February 7, 2019; (c) 92,592 time-based RSUs that were granted to him on February 6, 2020;
      (d) 115,000 Cristal transaction integration award performance-based RSUs that were granted to him on December 1, 2017; and (e) 50,000 Cristal transaction integration award performance-based RSUs that were granted to him on July 2, 2018.</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Quinn also shall remain eligible to vest in: (a) 68,748 time-based RSUs that were granted to him on February 7, 2019 and that are scheduled to vest on March 5, 2022;
      (b) 92,593 time-based RSUs that were granted to him on February 6, 2020 and that are scheduled to vest on March 5, 2022; (c) 92,593 time-based RSUs that were granted to him on February 6, 2020 and that are scheduled to vest on March 5, 2023; (d) a
      pro-rata portion of 206,243 Total Shareholder Return (&#8220;TSR&#8221;) performance-based RSUs that were granted to him on February 7, 2019 and that are scheduled to vest on March 5, 2022, with such pro-rata portion based on the number of calendar days between
      the grant date and his retirement date (March 18, 2021) divided by the number of calendar days between the grant date and March 5, 2022; and (e) a pro-rata portion of 138,889 Operating Return on Net Assets performance-based RSUs and the 138,889 TSR
      performance-based RSUs that were granted to him on February 6, 2020 and that are scheduled to vest on March 5, 2023, with such pro-rata portion based on the number of calendar days between the grant date and his retirement date (March 18, 2021)
      divided by the number of calendar days between the grant date and March 5, 2023.</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Quinn also shall receive continued medical and dental insurance coverage pursuant to COBRA until the earlier of: (i) the date on which he becomes eligible for such
      insurance through another employer; or (ii) the 18-month anniversary of his retirement date.</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The payments and benefits described above are subject to clawback and/or forfeiture under certain circumstances as more fully set forth in the Retirement Agreement. All
      payments and benefits provided to Mr. Quinn pursuant to the Retirement Agreement are subject to clawback in the event that the Board determines that he has engaged in any material wrongdoing related to his duties as a director or officer of the
      Company, or if the Board determines that he has materially breached any of his obligations under the Retirement Agreement. All vestings of RSUs scheduled to occur in 2022 and 2023 are subject to clawback and/or forfeiture in the event that Mr. Quinn
      is determined to have committed a material violation of law prior to his retirement date that was unrelated to his duties as an officer or director of the Company, as more fully set forth in the Retirement Agreement.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the Retirement Agreement is qualified in its entirety by reference to the Retirement Agreement filed herewith as Exhibit 10.1 and is
      incorporated by reference into this Item 5.02.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Employment Agreements of Mr. Romano and Mr. Turgeon</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The following description applies to the Employment Agreement dated March 18, 2021 between Mr. Romano and the Company (the &#8220;Romano Employment Agreement&#8221;) and the Employment
      Agreement dated March 18, 2021 between Mr. Turgeon and the Company (the &#8220;Turgeon Employment Agreement&#8221; and, together with the Romano Employment Agreement, each an &#8220;Employment Agreement&#8221;).</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Under each Employment Agreement, the applicable co-CEO shall be entitled to the following: (1) a base salary of not less than $900,000 per year; (b) an annual target bonus
      of not less than his annual salary; (c) a grant of long-term incentive compensation under the Company&#8217;s Long-Term Incentive Plan (&#8220;LTIP&#8221;) for 2021 in the amount of $2,200,000; (d) employee benefits as are made available by the Company to its senior
      executives, including medical, dental, vision, life and disability insurance, as well as participation in the Company&#8217;s 401(k) plan; and (e) an annual stipend of $10,000 for personal financial advisory and/or tax preparation services.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In the event that either co-CEO is terminated from his position without &#8220;Cause&#8221; or for &#8220;Good Reason&#8221; (as those terms are defined in the applicable Employment Agreement), he
      shall be entitled to a severance payment that includes: (a) two times the sum of his annual base salary and target bonus; (b) his COBRA expenses for up to the earlier of 18 months or the date on which he becomes eligible for group medical insurance
      through another employer; (c) a pro-rata portion of his annual bonus for the year in which his termination occurs with such calculation being based on the Company&#8217;s actual results of that year multiplied by the percentage of the year that he worked
      at the Company prior to his termination; and (d) the vesting of any equity awards based on the terms of such awards and their underlying plans. In order to receive such severance benefits, such co-CEO shall be obligated to enter into a Release
      Agreement that waives and releases any and all claims that he may have against the Company as of the date of the Release Agreement.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In the event that either co-CEO is terminated from his position without &#8220;Cause&#8221; or for &#8220;Good Reason&#8221; during the 90 days preceding or 24 months following a &#8220;Change of
      Control&#8221; (as those terms are defined in the applicable Employment Agreement), he shall be entitled to a severance payment that includes: (a) three times the sum of his annual base salary and target bonus; (b) his COBRA expenses for up to the earlier
      of 18 months or the date on which he becomes eligible for group medical insurance through another employer; (c) a pro-rata portion of his annual bonus for the year in which his termination occurs with such calculation being based on the Company&#8217;s
      actual results of that year multiplied by the percentage of the year that he worked at the Company prior to his termination; and (d) the accelerated and full vesting of all equity awards based on an assumption of performance at target levels. In
      order to receive such severance benefits, such co-CEO shall be obligated to enter into a Release Agreement that waives and releases any and all claims that he may have against the Company as of the date of the Release Agreement.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the Romano Employment Agreement and the Turgeon Employment Agreement is qualified in its entirety by reference to such respective agreement
      filed herewith as Exhibit 10.2 and 10.3, respectively, and each is incorporated by reference into this Item 5.02.</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="page-break-after:always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4fb3a2ab4a214ad6b1a5bb376eaab84e">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 7.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Regulation FD Disclosure.</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On March 18, 2021, the Company issued a press release relating to certain matters set forth in this Current Report on Form 8-K which is furnished herewith as Exhibit 99.1.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K is being &#8220;furnished&#8221; and shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18
      of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of that section and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act
      or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfc33a0d0ad604fe2883e73539b58c0fd">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Financial Statements and Exhibits.</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(d) Exhibits.</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z10789a5fd87e4be7844b206358c53b7d">


  <tr>

    <td style="width: 8%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit</div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">No.</div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div>
          </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10021910_ex10-1.htm">10.1</a></div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Retirement Agreement dated as of March 18, 2021 by and between the Company
                and Mr. </span>Jeffry N. Quinn</div>
          </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10021910_ex10-2.htm">10.2</a></div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Employment Agreement dated as of March </span>18<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, 2021 by and between the Company and Mr. </span>John D. Romano</div>
          </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10021910_ex10-3.htm">10.3</a></div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Employment Agreement dated as of March </span>18<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, 2021 by and between the Company and Mr. </span>Jean-Fran&#231;ois Turgeon</div>
          </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10021910_ex99-1.htm">99.1</a></div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Press Release, dated March </span>18<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, 2021</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">104</div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Inline XBRL for the cover page of this Current Report on Form 8-K</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="page-break-after:always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

    <div><br />
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
      duly authorized.</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd632dc21d4bf4b11b008ff9416714c1e">


  <tr>

    <td style="width: 45%; vertical-align: top;">&#160;</td>

    <td style="vertical-align: top; width: 3%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><br />
            </div>
          </td>

    <td style="vertical-align: top; font-weight: bold; width: 52%;">TRONOX HOLDINGS PLC</td>

  </tr>


</table>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45%; vertical-align: top;">&#160;</td>

    <td style="width: 3%; vertical-align: top;">&#160;</td>

    <td colspan="2" style="vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Date: March </span>18<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, 2021</span></div>
          </td>

    <td style="width: 3%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
          </td>

    <td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">/s/ Jeffrey N. Neuman</div>
          </td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">&#160;</td>

    <td style="width: 3%; vertical-align: top;">&#160;</td>

    <td style="width: 5%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Name:<br />
            </div>
          </td>

    <td style="width: 47%; vertical-align: top;">Jeffrey N. Neuman</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">&#160;</td>

    <td style="width: 3%; vertical-align: top;">&#160;</td>

    <td style="width: 5%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Title:<br />
            </div>
          </td>

    <td style="width: 47%; vertical-align: top;">Senior Vice President, General Counsel and Secretary</td>

  </tr>


</table>
    <div><br />
    </div>

  </div>

  <div><br />
  </div>

  <div>
    <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

  <div></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>brhc10021910_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font><!--PROfilePageNumberReset%Num%1%-%-%-->
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 10.1</font><font style="font-size: 10pt;"> <br>
    </font> </div>
  <font style="font-size: 10pt;"> </font>
  <div> <font style="font-size: 10pt;"><br>
    </font> </div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Retirement Agreement</div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">I, Jeffry N. Quinn, (&#8220;I&#8221; or &#8220;me&#8221;), am voluntarily and knowingly entering into this Retirement Agreement (the &#8220;Agreement&#8221;) with Tronox
    Holdings plc and all of its parent, subsidiary and affiliated companies (collectively referred to hereinafter as &#8220;Tronox&#8221; or the &#8220;Company&#8221;).</div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">I hereby resign from my positions as Chief Executive Officer and as Chair and as a member of the Board of Directors (the &#8220;Board&#8221;) of
    Tronox effective as of March 18, 2021 (the &#8220;Retirement Date&#8221;) pursuant to the terms and conditions set forth herein and in the Retirement Benefits Letter attached hereto as Appendix A (the &#8220;Retirement Benefits Letter&#8221;).</div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">I voluntarily enter into this Agreement with a full understanding of its contents and legal effects, as follows:</div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In consideration for the benefits described in the Retirement Benefits Letter, I now and forever release and discharge Tronox and all of its
    past and present employees, officers, directors, stockholders, owners, representatives, assigns, attorneys, agents, insurers, auditors, consultants and any other persons acting by, through, under, or in concert with any of the persons or entities
    listed in this section (each a &#8220;Released Party&#8221; or, collectively, the &#8220;Released Parties&#8221;) from any and all claims, suits, demands, liabilities, causes of action, or complaints of any kind or nature, including those for attorneys&#8217; fees, whether now
    known or unknown, suspected or unsuspected, which I may have had, or now have, against any of the Released Parties, which arise out of or are in any way connected with or are related to my employment with or my retirement from employment with any
    Released Party or Released Parties. This Agreement includes, but is not limited to, a waiver of all rights or claims I may have related to wrongful termination, breach of contract, impairment of economic opportunity, violation of public policy,
    intentional infliction of emotional harm, or any other common law or statutory contract or tort claims, the Age Discrimination in Employment Act of 1967, the Older Workers Benefit Protection Act, the Employee Retirement Income Security Act, 42 U.S.C.
    &#167;&#167;&#160;1981, 1983, and 1985, Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Family and Medical Leave Act, the Equal Pay Act, the Worker Adjustment and Retraining Notification Act, the Uniformed Services Employment and
    Reemployment Rights Act, or any other federal or state statute, municipal ordinance or governmental regulation relating to discrimination in employment or any other aspect of the employment relationship. This Agreement also includes, but is not limited
    to, a waiver of all rights or claims I may have against any of the Released Parties arising under the laws of the United Kingdom or any other jurisdiction.&#160; I understand that this Agreement is a bar against, and I am relinquishing my right to assert
    claims against the Released Parties arising under any of the foregoing laws.</div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Examples of released claims include, but are not limited to: (i) claims that in any way relate to my employment with any of the
    Released Parties, or my retirement from that employment, such as claims for compensation, bonuses, commissions, restricted stock units or lost wages; (ii) claims that in any way relate to the design or administration of Tronox&#8217;s severance plan or any
    other employee benefit program; (iii) claims that I have irrevocable or vested rights to any severance benefits, post-employment health or group insurance benefits, or similar benefits (other than as described in the Retirement Benefits Letter); (iv)
    any claim, such as a benefit claim, that was explicitly or implicitly denied before I signed this Agreement; (v) any claim I might have for extra benefits as a consequence of payments I receive because of signing this Agreement, and (vi) any claim for
    attorneys&#8217; fees except as may arise from my rights to indemnification set forth herein. The foregoing notwithstanding, nothing herein shall be deemed to waive, and released claims shall not include:&#160; (i) my right to receive the payments and benefits
    described in the Retirement Benefits Letter, (ii) any vested benefit I have under any Tronox qualified or non-qualified retirement, welfare or other employee benefit plan, (iii) rights to indemnification from any Released Party, (iv) any rights under
    any directors and officers insurance policy maintained by any of the Released Parties or (v) any rights I may have as a shareholder of the Company.</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-size: 10pt;"><br>
    </font> </div>
  <font style="font-size: 10pt;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-1-</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">This



        Agreement does not waive any rights or claims that I may have that first arise after the date I sign this Agreement.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">This



        Agreement does not waive any rights or claims that I may have to receive compensation for work-related injuries or illnesses under any workers&#8217; compensation statute. This Agreement also does not in any way prohibit me from filing any complaint with
        or participating in any investigation conducted by any government agency (e.g., the Equal Employment Opportunity Commission, the Securities and Exchange Commission, the Department of Labor, etc.); provided, however, that I hereby agree not to seek
        or accept any monetary compensation, payment or awards (including, but not limited to, any whistleblower fees or awards) arising from or related to any such complaint or participation by me.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">I
        understand that a Released Party will provide me with the payments and benefits set forth in the Retirement Benefits Letter. I further understand that I would not be eligible for any such payments and benefits but for my execution of and compliance
        with this Agreement and agreeing to all of the terms and obligations herein, as indicated by my signature below.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">5.</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">I
        understand that the payments and benefits provided in the Retirement Benefits Letter constitute a final accord and satisfaction of all sums of money and benefits due from any Released Parties in association with my retirement from employment,
        specifically including any amount which may be due under any written or oral employment agreement with a Released Party, and this Agreement waives all rights or claims, as set out in Paragraph 1 above, arising under my employment agreement dated
        March 28, 2019 (the &#8220;Employment Agreement&#8221;). I also understand that my signing this Agreement will terminate Tronox&#8217;s obligations under the Employment Agreement and under any other written or oral employment agreement and/or separation agreement
        between any Released Party and me. Any provisions of the Employment Agreement intended by the parties to survive after termination of my employment shall survive, according to the terms thereof, including, but not limited to, all of my obligations
        related to non-disclosure of confidential information, return of Company property, non-disparagement, non-competition and non-solicitation, and arbitration of disputes as set forth in my Employment Agreement.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">6.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">To
        the fullest extent permitted by law, I waive and give up each and every right or benefit that I may have under common law or any statutory provision to limit the scope of the general release of claims that I provided pursuant to Paragraph 1 above.
        This includes the right to exclude from the general release any claims or facts that I do not know or suspect exist at the time of executing this Agreement and that, if I had known, materially would have affected this Agreement. This Agreement is
        effective and shall remain effective notwithstanding the discovery or existence of any such additional claims or facts.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-2-</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; margin-right: 3.6pt; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;I shall not knowingly use or disclose to any third party any confidential information regarding the Released Parties, except as may otherwise be required by law. I understand that
      confidential information consists of any and all information not generally known to members of the public that I obtained or became aware of during my employment with a Released Party, or its predecessor, that is considered by the foregoing to be
      valuable or otherwise confidential. This restriction against the use or disclosure of confidential information shall apply for a period of ten (10) years, except with respect to confidential information that also constitutes trade secrets in which
      case this restriction against use or disclosure shall not be limited in duration. I agree that within one week of the Retirement Date, I will return to the General Counsel of Tronox any confidential information in my possession, custody or control
      and I shall not keep any copies (written, electronic or otherwise) of any such confidential information. Within one week of the Retirement Date, I also shall return to the General Counsel of Tronox all Tronox property in my possession, custody or
      control, including, but not limited to, all access cards, credit cards, electronic equipment, laptop computers, etc.</font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">I
        agree that I will not serve as a consultant or expert witness for any party asserting any claims against any of the Released Parties, whether such claims are asserted informally or through any formal judicial, arbitral, or similar such proceedings.
        I understand I am not prohibited from providing complete, responsive and truthful information to any government official or agency, to any court or responding to a valid subpoena. I agree, however, to give advance notice as soon as possible to the
        Released Parties before providing any such information or testimony.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">I
        agree I shall not willfully make any public statement or perform or do any other act that disparages or is prejudicial or injurious to the reputation or goodwill of or otherwise interferes with the business of Tronox.&#160; Tronox agrees that the
        members of its Board and its officers shall not willfully make any public statement or perform or do any other act that disparages or is prejudicial or injurious to my reputation.&#160; Notwithstanding the foregoing, nothing herein shall prevent any
        member of Tronox&#8217;s Board, any of its officers, or me from providing truthful information in any legal proceeding or as otherwise may be required by law.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Tronox



        agrees that my retirement will be announced by Tronox by a press release and internal announcement that is reasonably acceptable to me.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">I
        agree that remedies at law for a breach or threatened breach of this Paragraph 7 would be inadequate. In recognition of this fact, I agree that, in the event of such a breach or threatened breach, in addition to any remedies at law, a Released
        Party or Parties, without posting any bond, shall be entitled to seek equitable relief in the form of specific performance, temporary restraining order, temporary or permanent injunction or any other equitable remedy that may then be available.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">I
        understand and agree that I shall not apply for employment with Tronox at any time in the future and that, should I apply for any such position, Tronox shall have no obligation to consider me for any position.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Tronox



        agrees that upon twenty (20) days written notice, which notice may be delivered at any time within eighteen (18) months after the Retirement Date, it will arrange for the delivery of my personal property from my office and that which is displayed
        or stored at the Company&#8217;s New York offices including, but not limited to my artwork, furniture and oriental rugs, to a location in Miami, Florida that I designate in writing; provided that with respect to any documents that are physically located
        in my office, the Company shall have the right to make and retain copies of all such documents.&#160; I shall pay for the cost of such delivery and the Company shall reimburse me for 50% of such cost upon my submission of proof of payment for same.&#160; The
        Company will provide reasonable access to my representative (who shall be a person reasonably acceptable to the Company), or otherwise make reasonable arrangements, to enable me to ascertain that all of my personal property has been properly
        identified and delivered.</font></font></div>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
      </font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-3-</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; margin-right: 3.6pt; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">I agree that the Company
      shall have the right either not to provide me with or, to the extent they already have been provided to me, to recover from me the RSU Clawback or the Full Clawback (as those terms are defined below) if there is a &#8220;Clawback Event&#8221; (as that term is
      defined below). For the purposes of this Agreement, a Clawback Event shall be defined to have occurred if, on or before March 31, 2023: &#160;(a) I am arrested, charged or indicted for a felony related to conduct in which I allegedly engaged prior to the
      Retirement Date; (b) I am named as a defendant, respondent or otherwise as a party in any civil action or administrative proceeding filed or initiated by the Securities and Exchange Commission (the &#8220;SEC&#8221;) related to conduct in which I allegedly
      engaged prior to the Retirement Date; (c) the Board determines through a written resolution passed by at least two-thirds of the Company&#8217;s non-employee directors that I engaged in material wrongdoing related to my services as an officer or director
      of the Company, including, but not limited to, any such wrongdoing that may be alleged in connection with an (a) or (b) event above; or (d) the Board determines through a written resolution passed by at least two-thirds of the Company&#8217;s non-employee
      directors that I breached any of my material obligations under this Agreement and such breach is not cured (if curable as determined by the Board) within fifteen (15) days of my receipt of written notice from the Board.&#160; If a Clawback Event occurs
      pursuant to (a) or (b) above, I no longer shall be entitled to receive the vesting of the RSUs as set forth in Paragraphs 3(b)(2)-(3) and 3(c)(2)-(3) of the Retirement Benefits Letter (collectively referred to as the &#8220;RSU Clawback&#8221;).&#160; If a Clawback
      Event occurs pursuant to (c) or (d) above, regardless of whether or not a Clawback Event also has occurred under (a) or (b) above, I no longer shall be entitled to receive the 2020 AIP bonus set forth in Paragraph 1 of the Retirement Benefits Letter
      or the vesting of any of the RSUs as set forth in Paragraphs 3(a), 3(b)(1)-(3), 3(c)(1)-(3) and 3(d) of the Retirement Benefits Letter (collectively referred to as the &#8220;Full Clawback&#8221;). As of the date on which the Company signs this Agreement, it is
      not aware of any conduct by me that would trigger a Clawback Event pursuant to (c) or (d) above. In the event that I already have received some or all of the benefits subject to the RSU Clawback or the Full Clawback, I agree to repay such benefits to
      the Company within fifteen (15) days after receiving written notice from the Company of a Clawback Event (with such repayment regarding the RSUs being equal to the market value of the RSUs as of their respective vesting dates).&#160; I shall have the
      right to dispute the alleged occurrence of a Clawback Event by providing a detailed written explanation as to my reasons for disputing the Clawback Event to the Board within fifteen (15) days of receiving written notice of a Clawback Event.&#160; The
      Company then shall have the right to seek to recover the RSU Clawback or the Full Clawback (depending on the applicable Clawback Event) by filing an arbitration claim in accordance with Paragraph 21 of this Agreement, which incorporates by reference
      the Arbitration provision in my Employment Agreement.&#160; Notwithstanding the foregoing, absent the occurrence of a Clawback Event under (c) or (d) above, I shall not be subject to a Clawback Event under (a) or (b) above if any and all criminal, civil
      and/or administrative proceedings against me are unconditionally dismissed with prejudice and without me entering into any non-prosecution agreement, deferred prosecution agreement, consent agreement, plea agreement, civil settlement or other similar
      negotiated resolution (regardless of whether I do or do not admit any wrongdoing, liability or guilt in any such agreement or resolution); provided, however, that any civil settlement or other similar negotiated resolution with the SEC regarding a
      matter described in clause (b) above&#160; that does not involve material wrongdoing related to my services as an officer or director of the Company shall not be a Clawback Event unless the Board determines through a written resolution passed by at least
      two-thirds of the Company&#8217;s non-employee directors that such civil settlement or other similar negotiated resolution would have been reasonably likely to bring substantial public disgrace or disrepute to the Company if I had entered into it while
      serving as the Chief Executive Officer of the Company.</font></div>
  <div style="text-align: justify; margin-right: 3.6pt; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
    </font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-4-</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; margin-right: 3.6pt; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">9.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Except to the extent otherwise
      set forth in Paragraph 3(e) of the Retirement Benefits Letter, I am responsible for paying any taxes on amounts I receive because I signed this Agreement and I agree that the Released Party making the payments set forth in the Retirement Benefits
      Letter is authorized to withhold all taxes it determines it is legally required to withhold. I also agree to indemnify and hold harmless Tronox from any tax liabilities, interest or penalties that may arise from any failure by me to pay any income
      taxes or other taxes arising from my receipt of any of the payments and benefits set forth in the Retirement Benefits Letter. The foregoing notwithstanding, Tronox agrees that it retains full responsibility for paying the employer&#8217;s portion of any
      payroll taxes arising from the payments and benefits set forth in the Retirement Benefits Letter.</font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">10.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">I
        agree that for up to eighteen (18) months after the Retirement Date, I shall use my best efforts to consult with, cooperate with and provide reasonable assistance to Tronox in any internal or external investigation, arbitration, litigation,
        administrative proceeding, regulatory inquiry or other matter that relates to or arises from any of my work or knowledge on behalf of Tronox, including, but not limited to, in the matter of <font style="font-family: 'Times New Roman'; font-style: italic;">Tronox v. Venator</font>. Such cooperation shall include, but not be limited to, conferring with Tronox&#8217;s senior executive personnel, ,members of its Board of Directors, its counsel and its other advisors, attending depositions, making
        court appearances, and providing other reasonable assistance in all such matters.&#160; In connection therewith, Tronox agrees to compensate me for my time at the rate of $500/hour, to reimburse me for reasonable and necessary out-of-pocket expenses,
        such as travel, meals, or lodging and indemnify and hold me harmless for any liabilities I may incur as a result of such consultation, cooperation or assistance.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">11.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">I
        understand and agree that the Company shall be required to disclose the terms and conditions of this Agreement, as well as a copy of this Agreement and of the Retirement Benefits Letter pursuant to the requirements of the United States securities
        laws and similar laws in other jurisdictions.&#160; I further acknowledge and agree that the Released Parties and/or I may use this Agreement as evidence in any proceeding arising from or related to this Agreement.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">12.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">My
        heirs, executors, administrators, legal representatives, successors and assigns, and the successors and assigns of the Company, shall be bound by this Agreement.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">13.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Except



        as indicated in the last sentence of Paragraph 5 above, this Agreement constitutes the full and complete agreement between the Released Parties and me. I understand that neither I nor any of the Released Parties is authorized to make any
        modifications to this Agreement, unless such modifications are in writing and signed by the same parties that sign this Agreement.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">14.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Nothing



        in the Retirement Benefits Letter or in this Agreement is intended by the Released Parties or me to imply that any party has done anything wrong.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">15.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If
        any provision of this Agreement is determined to be null, void, inoperative or unenforceable, the parties jointly request that such provision be deemed modified to the least extent necessary so as to render it legal and enforceable. To the extent
        that such modification cannot be accomplished, such provision shall be deemed to be stricken from this Agreement, the remaining provisions shall be considered separate from the stricken provision and the remaining provisions shall remain in full
        force and effect.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">16.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">I
        have been advised to discuss this Agreement with an attorney of my choice, at my own expense, and I acknowledge that I have discussed this Agreement with my attorneys at the law firm of Fried Frank LLP.&#160; I acknowledge that no one made any
        representations to me about the Retirement Benefits Letter or this Agreement other than as set forth in writing herein, and that I have read and understand the provisions of this Agreement. I knowingly and voluntarily sign this Agreement on the
        date set forth below.</font></font></div>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
      </font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-5-</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; margin-right: 3.6pt; font-size: 10pt;">&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">17.</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">I acknowledge that the
      payments and benefits made available to me hereunder pursuant to the Retirement Benefits Letter are sufficient consideration for this Agreement.</font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">18.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">I
        agree to withdraw or dismiss with prejudice all complaints, if any, that I have filed or may file against any Released Party with any court or in any other forum that are within the scope of claims released herein. I promise never to seek any
        damages, remedies or other relief for myself personally (any right to which I hereby waive) with respect to any claim released by this Agreement. I agree to pay the reasonable attorneys&#8217; fees and any damages any of the Released Parties may incur as
        a result of my bringing an action against any Released Party based on a claim that was validly released under Paragraph 1 above.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">19.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">I
        acknowledge that I have received at least twenty-one (21) days to consider this Agreement. I understand that I can timely accept this Agreement only by actual delivery of the signed Agreement in person, by mail or by email to Jeffrey Neuman,
        General Counsel, Tronox Holdings plc, 263 Tresser Blvd., Suite 1100, Stamford, CT 06901. In order to timely accept this Agreement, such delivery of my signed Agreement must occur at any time between the date on which I first received this Agreement
        and twenty-one (21) days thereafter.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">20.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">I
        understand I may revoke this Agreement within seven (7) calendar days following the date on which I signed this Agreement (the &#8220;Revocation Period&#8221;), in which case I will not be entitled to receive the payments and benefits set forth in the
        Retirement Benefits Letter. This Agreement shall not be effective or enforceable until that seven (7) day period for revocation has expired. I understand that any revocation of this Agreement must be in writing and must be sent or delivered to
        Jeffrey Neuman, General Counsel, Tronox Holdings plc, 263 Tresser Blvd, Suite 1100, Stamford, CT 06901. To be effective, any revocation must be received by Jeffrey Neuman no later than 5:00 p.m. Eastern Time within seven (7) days following my
        execution of this Agreement (or if that day falls on a Saturday, Sunday or legal holiday, the next regular business day thereafter).&#160; If no such revocation is received within such seven (7) day period, this Agreement shall be effective as of the
        eighth day after I sign it (or if that day falls on a Saturday, Sunday or legal holiday, the next regular business day thereafter) (the &#8220;Effective Date&#8221;).</font></font></div>
  <div style="text-align: justify; margin-right: 3.6pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
      </font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-6-</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">21.</font>&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">This Agreement shall be governed by and interpreted
      in accordance with Connecticut law. In the event of any dispute related to or arising from this Agreement, including, but not limited to, the Retirement Benefits Letter, such dispute shall be resolved pursuant to the arbitration provision set forth
      in my Employment Agreement, which hereby is incorporated herein by reference.</font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">PLEASE CAREFULLY READ THIS RETIREMENT AGREEMENT AS IT CONTAINS A GENERAL RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS.</div>
  <font style="font-size: 10pt;"> </font>
  <div><font style="font-size: 10pt;">&#160; <br>
    </font> </div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Executed this 18th day of March, 2021</div>
  <font style="font-size: 10pt;"> </font>
  <div><font style="font-size: 10pt;"><br>
    </font> </div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;">
    <table cellspacing="0" cellpadding="0" border="0" id="zfa9ff11371564ca38a8c3ae0074e5e33" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">/s/ Jeffry N. Quinn</div>
          </td>
          <td style="width: 60%; padding-bottom: 2px;">
            <div style="font-size: 10pt;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%;">
            <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jeffry N. Quinn</div>
          </td>
          <td style="width: 60%;">
            <div style="font-size: 10pt;">&#160;</div>
          </td>
        </tr>

    </table>
  </div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"> <font style="font-size: 10pt;"><br>
    </font> </div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Executed this 18th day of March, 2021, on behalf of Tronox Holdings plc</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
    <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Ilan Kaufthal</div>
            </td>
            <td style="width: 60%; padding-bottom: 2px;">
              <div style="font-size: 10pt;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 40%;">
              <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Ilan Kaufthal, Chairman of the Board</div>
            </td>
            <td style="width: 60%;">
              <div style="font-size: 10pt;">&#160;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
  <div><font style="font-size: 10pt;"><br>
    </font> </div>
  <font style="font-size: 10pt;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-7-</font></div>
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <!--PROfilePageNumberReset%Num%1%A-%%-->
  <div style="text-align: center; margin-left: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Appendix A - Retirement Benefits Letter</div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As consideration for the foregoing Retirement Agreement (the &#8220;Agreement&#8221;) that I have provided to Tronox Holdings plc and all of its
    parent, subsidiary and affiliated companies (collectively referred to hereinafter as &#8220;Tronox&#8221; or the &#8220;Company&#8221;)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>, the Company and I agree as follows:</div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 28.8pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Annual Incentive Plan</u></font>. The Company shall pay me a 2020 Annual Incentive Plan (&#8220;AIP&#8221;) bonus at&#160; 150% of Target, which amount shall be $2,062,500, less 50% of the cost of my 2020 use of the
        Company aircraft (50% of $183,288 = $91,644) and my personal expenses ($490), for a net payment of $1,970,366, prior to applicable tax withholdings and deductions. Such payment shall be made on the later of the date that 2020 AIP bonuses are paid
        to other executives of Tronox, or on the second business day after the Effective Date.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: left; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Long Term Incentive Plan</u></font>. I shall not receive any Long-Term Incentive Plan (&#8220;LTIP&#8221;) Award for 2021.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: left; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Restricted Stock Unit Awards</u></font>.&#160; My Restricted Stock Unit (&#8220;RSU&#8221;) Awards shall vest as set forth below:</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcf30002ccee444a4b9ddb3064787f880">

      <tr>
        <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
          </font> </td>
        <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>2/8/18 RSU Grant</u></font><font style="font-size: 10pt;"> &#8211; 30,239 time-based RSUs and 36,014
              performance RSUs shall vest on the second business day after the Effective Date.</font></div>
        </td>
      </tr>

  </table>
  <font style="font-size: 10pt;"> </font>
  <div><font style="font-size: 10pt;">&#160; <br>
    </font> </div>
  <font style="font-size: 10pt;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb3969a49d5944f79b9b766e62b6d1515">

      <tr>
        <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
          </font> </td>
        <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>2/7/19 RSU Grant</u></font><font style="font-size: 10pt;"> &#8211;</font></div>
        </td>
      </tr>

  </table>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z257382e7d1ee48148355951fa95e75dc">

      <tr>
        <td style="width: 90pt;"><font style="font-size: 10pt;"><br>
          </font> </td>
        <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">68,748 time-based RSUs shall vest on the second business day after the Effective Date;</div>
        </td>
      </tr>

  </table>
  <font style="font-size: 10pt;"> </font><font style="font-size: 10pt;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z664f523fcd6349398acc99a0efe279bd">

      <tr>
        <td style="width: 90pt;"><font style="font-size: 10pt;"><br>
          </font> </td>
        <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">all remaining time-based RSUs shall remain outstanding and shall vest on the date(s) specified in the award agreement for this grant;</div>
        </td>
      </tr>

  </table>
  <font style="font-size: 10pt;"> </font><font style="font-size: 10pt;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc06f479ecafe485e974f330aeaec868f">

      <tr>
        <td style="width: 90pt;"><font style="font-size: 10pt;"><br>
          </font> </td>
        <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: 'Times New Roman'; font-size: 10pt;">a pro-rata portion of the 206,243 unvested TSR performance RSUs shall remain outstanding and shall be eligible to vest based upon the Company&#8217;s actual performance over the Measurement
            Period, with such pro-rata amount determined by multiplying the number of such TSR performance RSUs that are eligible to become vested on March 5, 2022 by a fraction, the numerator of which is the number of calendar days from the grant date to
            the Effective Date and the denominator of which is the number of calendar days from the grant date to the March 5, 2022 vesting date.&#160; My retirement shall not accelerate the vesting of any such RSUs.</div>
        </td>
      </tr>

  </table>
  <font style="font-size: 10pt;"> </font>
  <div><font style="font-size: 10pt;">&#160; <br>
    </font> </div>
  <font style="font-size: 10pt;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z112daecbb5fe43c6a2bf15e8f710ed0e">

      <tr>
        <td style="width: 32.1pt;"><font style="font-size: 10pt;"><br>
          </font> </td>
        <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>2/6/20 RSU Grant</u></font><font style="font-size: 10pt;"> &#8211;</font></div>
        </td>
      </tr>

  </table>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zec2e75243cb84510b7174ec5daa6c1aa">

      <tr>
        <td style="width: 90pt;"><font style="font-size: 10pt;"><br>
          </font> </td>
        <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">92,592 time-based RSUs shall vest on the second business day after the Effective Date;</div>
        </td>
      </tr>

  </table>
  <font style="font-size: 10pt;"> </font><font style="font-size: 10pt;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za798e4a7baba4a32baea74f1ff16f4f5">

      <tr>
        <td style="width: 90pt;"><font style="font-size: 10pt;"><br>
          </font> </td>
        <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">all remaining time-based RSUs shall remain outstanding and shall vest on the date(s) specified in the award agreement for this grant;</div>
        </td>
      </tr>

  </table>
  <font style="font-size: 10pt;"> </font><font style="font-size: 10pt;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za8aacd1284c846c3ab91642e22f4da4b">

      <tr>
        <td style="width: 90pt;"><font style="font-size: 10pt;"><br>
          </font> </td>
        <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">a pro-rata portion of the 138,889 unvested ORONA performance RSUs and of the 138,889 unvested TSR
              performance RSUs shall remain outstanding and shall be eligible to vest based upon the Company&#8217;s actual performance over the Measurement Period, with such pro-rata amount determined by multiplying the number of such ORONA and TSR performance
              RSUs that are eligible to become vested on March 5, 2023 by a fraction, the numerator</font><font style="font-size: 10pt; font-family: 'Times New Roman';"> of which is the number of calendar days from the grant date to the Effective Date and
              the denominator of which is the number of calendar days from the grant date to the March 5, 2023 vesting date</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">.&#160; </font><font style="font-size: 10pt; font-family: 'Times New Roman';">My retirement shall not accelerate the vesting of any such RSUs.</font></div>
        </td>
      </tr>

  </table>
  <font style="font-size: 10pt;"> </font>
  <div><font style="font-size: 10pt;">&#160;</font></div>
  <div><font style="font-size: 10pt;"></font>
    <hr noshade="noshade" align="left" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto 0px 0px; height: 2px; width: 20%; color: #000000; text-align: left;">
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="align: right; vertical-align: top; width: 9pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">All capitalized terms herein shall have the same meaning as such capitalized terms in the Retirement Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
  </div>
  <font style="font-size: 10pt;"> </font>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">A-1</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb8cbc2787f464f8f9d4ae04bc9b2922c">

      <tr>
        <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
          </font> </td>
        <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Integration Awards</u></font><font style="font-size: 10pt;"> &#8211; 115,000 Integration RSUs granted on
              12/1/17 and 50,000 Integration RSUs granted on 7/2/18 shall vest on the second business day after the Effective Date.</font></div>
        </td>
      </tr>

  </table>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za6461d9e9d494453a557a8ee4159ca75">

      <tr>
        <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
          </font> </td>
        <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(e)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"><u>United Kingdom Tax Treatment</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> - Consistent with past practice, I shall receive </font><font style="font-size: 10pt; font-family: 'Times New Roman';">tax equalization from the Company for personal income taxes in the United Kingdom (&#8220;UK&#8221;) that become due
              and payable with respect to any of the Restricted Stock Unit Awards described in (a)-(d) above </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">(the &#8220;RSU Awards&#8221;).&#160; The Company shall determine the
              applicable United States withholding taxes on the RSU Awards, deduct this amount from the number of shares delivered to me upon vesting or settlement, and shall prepare and file on my behalf any submissions required to be made to the United
              Kingdom tax authorities and shall pay on my behalf any personal income taxes arising in the United Kingdom on the RSU Awards.&#160; I understand and agree that I will review and approve, by signature or other means as required, the 2020/21 UK tax
              filing and the 2021/22 UK tax filing in a timely manner and in advance of the UK tax filing deadlines.&#160; I understand and agree that, notwithstanding the foregoing, I solely shall be responsible for paying any taxes arising in the United
              States related to the&#160; RSU Awards and all other payments and benefits received by me pursuant to this Retirement Benefits Letter.</font></div>
        </td>
      </tr>

  </table>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: left; margin-right: 7.2pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Retirement Savings Plan</u></font>. As of my Retirement Date, I am fully vested in my account balances in the Company&#8217;s 401(k) Plan and BRP Plan.&#160; I shall not be eligible to receive or make any further
        contributions to these Plans on or after my Retirement Date. Distribution of my account balances shall be made in accordance with the terms of those plans.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: left; margin-right: 7.2pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">5.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Non-Qualified Deferred Compensation Plan</u></font>. As of my Retirement Date, I am fully vested in my account balances in the Company&#8217;s Savings Restoration Plan.&#160; Distribution of my account balance
        shall be made in accordance with the terms of that plan.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: left; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">6.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Employee Benefits and COBRA</u></font>. After the Retirement Date, I no longer shall receive any employee benefits from the Company, except that the Company shall, following the Retirement Date, continue
        to provide medical and dental insurance coverage to me pursuant to COBRA on the same terms as an active employee until the earlier of: (a) my eligibility for medical and/or dental insurance through another employer; or (b) the&#160; eighteen (18) month
        anniversary of my Retirement Date.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: left; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">7.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Clawback</u></font>. I agree that certain of the benefits set forth herein shall be subject to the Clawback set forth in Paragraph 8 of my Retirement Agreement.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: left; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">8.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>No Other Compensation or Benefits</u></font>. I acknowledge and agree that, except as expressly provided in this Retirement Benefits Letter, or as otherwise required by applicable law, I shall not be
        entitled to receive any compensation, severance or other benefit from the Company other than as set forth in this Retirement Benefits Letter. Without limiting the foregoing, I specifically acknowledge and agree that I shall not be entitled to any
        compensation, severance or other benefit arising from my Employment Agreement, from the Company&#8217;s Severance Plan or from any other source except as enumerated above in this Retirement Benefits Letter.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">A-2</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: left; margin-right: 3.6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">9.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Advice of Counsel</u></font>.&#160; I acknowledge and agree that the Company has advised me to discuss this Retirement Benefits Letter with an attorney of my choice, at my own expense, and I acknowledge that
        I have discussed this Retirement Benefits Letter with my attorneys at the law firm of Fried Frank LLP.&#160; I acknowledge that no one made any representations to me about this Retirement Benefits Letter other than as set forth in writing herein, and
        that I have read and understand the provisions of this Retirement Benefits Letter.&#160; I knowingly and voluntarily sign this Retirement Benefits Letter on the date set forth below.</font></font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: justify; margin-right: 3.6pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Executed this 18th day of March, 2021</div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div>
    <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 50.03%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="font-size: 10pt;">/s/ Jeffry N. Quinn</div>
            </td>
            <td style="width: 50.03%; padding-bottom: 2px;">
              <div style="font-size: 10pt;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50.03%;">
              <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jeffry N. Quinn</div>
            </td>
            <td style="width: 50.03%;">
              <div style="font-size: 10pt;">&#160;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <font style="font-size: 10pt;"> &#160; </font>
  <div style="text-align: justify; margin-right: 3.6pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Executed this 18th day of March, 2021, on behalf of Tronox Holdings plc</div>
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt;">&#160;</div>
  <font style="font-size: 10pt;"> </font>
  <div>
    <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 50.03%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-size: 10pt;">/s/ Ilan Kaufthal</div>
              </td>
              <td style="width: 50.03%; padding-bottom: 2px;">
                <div style="font-size: 10pt;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50.03%;">
                <div style="text-align: justify; margin-right: 3.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Ilan Kaufthal, Chairman of the Board</div>
              </td>
              <td style="width: 50.03%;">
                <div style="font-size: 10pt;">&#160;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
  <div><font style="font-size: 10pt;"><br>
    </font> </div>
  <font style="font-size: 10pt;"> <br>
  </font>
  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"> <font id="DSPFPageNumber" style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">A-3</font></div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>brhc10021910_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Exhibit 10.2<br>
      </div>
      <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CO-CHIEF EXECUTIVE OFFICER</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EMPLOYMENT AGREEMENT</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; margin-right: 3.6pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">This CO-CHIEF EXECUTIVE OFFICER EMPLOYMENT AGREEMENT (the &#8220;<font style="font-family: 'Times New Roman';"><u>Agreement</u></font>&#8221;)
        is entered into as of this 18th day of March 2021 (the &#8220;<font style="font-family: 'Times New Roman';"><u>Effective Date</u></font>&#8221;) by and between Tronox Holdings plc (together with its successors and assigns, the &#8220;<font style="font-family: 'Times New Roman';"><u>Company</u></font>&#8221;), and John D. Romano, an individual (the &#8220;<font style="font-family: 'Times New Roman';"><u>Executive</u></font>&#8221; or &#8220;<font style="font-family: 'Times New Roman';"><u>you</u></font>&#8221;).</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; margin-right: 3.6pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, you are currently employed as the Interim Co-Chief Executive Officer of the Company pursuant to a
        Letter Appointment dated December 27, 2020 and an Amended and Restated Employment Agreement dated December 23, 2014 (collectively the &#8220;<font style="font-family: 'Times New Roman';"><u>Prior Employment Agreement</u></font>&#8221;); and</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; margin-right: 3.6pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, you and the Company desire to terminate the Prior Employment Agreement and to enter into this
        Agreement to set out the terms and conditions for the continued employment relationship between you and the Company.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; margin-right: 3.6pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein and for other good
        and valuable consideration, the receipt and sufficiency of which hereby are acknowledged, the parties hereto agree as follows:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Start Date</u></font>.&#160; Your new position with the Company as described in this Agreement will be effective as of the Effective Date.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Place of Employment</u></font>.&#160; During your employment pursuant to this Agreement, you may maintain your personal residence at a location of your own choice and work from such location, <font style="font-family: 'Times New Roman';"><u>provided</u></font> that:&#160; (i) you are present at the Company&#8217;s corporate headquarters, currently located at One Stamford Plaza, 263 Tresser Boulevard, Stamford, Connecticut 06901 (the &#8220;Corporate
            Headquarters&#8221;), and/or at the Company&#8217;s offices in New York City (the &#8220;NYC Office&#8221;), as necessary or advisable to effectively manage and execute the business of the Company; and (ii) subject to paragraph 31, you bear all responsibility for
            personal income taxes in connection with your personal residence decisions.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Position and Duties</u></font>.&#160; You will be employed by the Company as its Co-Chief Executive Officer, and together with the other Co-Chief Executive Officer, you will serve as the most senior
            executive officers of the Company, reporting directly to the Board of Directors of the Company (the &#8220;<font style="font-family: 'Times New Roman';"><u>Board</u></font>&#8221;). You will have the normal duties, responsibilities and authority implied by
            such position, subject to the power of the Board to expand such duties or limit such duties (subject to your rights as set forth in this Agreement, including your right to resign for Good Reason as set forth herein).&#160; The Board will elect you
            as a member of the Board as soon as it can do so subject to ensuring that a majority of the members of the Board meet the independence rules of the New York Stock Exchange.&#160; In addition, the Company and the Board shall take such action as may
            be necessary or appropriate to nominate you for re-election as a member of the Board at the expiration of the then current term. Notwithstanding the foregoing, if you are requested to resign from the Board at any time, you agree to do so
            immediately upon receiving such a written request from the Chair of the Board or the Lead Director as the case may be.<br>
            <br>
          </font></font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Exclusive Service</u></font>.&#160; You will devote your work time, efforts and attention to the business and affairs of the Company; <font style="font-family: 'Times New Roman';"><u>provided</u></font>
            that you may serve on the boards of directors of philanthropic or civic organizations and on the board of directors of one for-profit company; <font style="font-family: 'Times New Roman';"><u>provided</u></font> such service or participation
            does not interfere with your employment or duties under this Agreement and that you have advised the Board prior to commencing and the Board has consented in writing (which consent shall not be unreasonably withheld or delayed) to such outside
            activities.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">5.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Termination of Prior Employment Agreement</u></font>.&#160; Upon the Effective Date of this Agreement, it shall supersede and replace your Prior Employment Agreement, which shall be of no further
            force or effect.&#160; Notwithstanding the foregoing, within ten (10) business days of the Effective Date, the Company shall pay you the one-time special bonus of $500,000 as set forth in paragraph (b) of your Letter Appointment dated December 27,
            2020.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">6.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Base Salary</u></font>.&#160; During your employment pursuant to this Agreement, the Company will pay you a base salary at a rate of no less than $900,000/year, which amount may be increased (but
            not decreased) from time to time by the Human Resources and Compensation Committee of the Board (the &#8220;<font style="font-family: 'Times New Roman';"><u>HRCC</u></font>&#8221;) (the annual base salary as increased from time to time, the &#8220;<font style="font-family: 'Times New Roman';"><u>Annual Base Salary</u></font>&#8221;). The Annual Base Salary will be payable in accordance with the Company&#8217;s normal payroll practices, with such deductions and withholdings as are required by law.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">7.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Bonus</u></font>.&#160; During your employment pursuant to this Agreement, you will be eligible to receive a cash bonus under the Company&#8217;s Annual Incentive Plan (&#8220;<font style="font-family: 'Times New Roman';"><u>AIP</u></font>&#8221;) or other similar bonus plan adopted by the Board or the HRCC (an &#8220;<font style="font-family: 'Times New Roman';"><u>Annual Bonus</u></font>&#8221;) in an amount targeted on an annual basis at no less than 100%
            of your Annual Base Salary (or such higher amount for any fiscal year as may be determined by the HRCC from time to time) (the &#8220;<font style="font-family: 'Times New Roman';"><u>Target Bonus</u></font>&#8221;), with a maximum Annual Bonus opportunity
            of up to 200% of the Target Bonus, in each case, based upon your and/or the Company&#8217;s attainment of one or more objective performance criteria established in writing by the Board or HRCC. The Company will pay your Annual Bonus, if any, in the
            year following the year to which such Annual Bonus relates at the same time such AIP bonuses are paid to similarly situated executives of the Company.&#160; If terminated for Cause, the Annual Bonus shall not be deemed to be earned until the date on
            which it is paid by the Company.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">8.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Long-Term Incentive Compensation</u></font>.&#160; During your employment pursuant to this Agreement, you will be eligible to receive an annual grant of long-term compensation under the Company&#8217;s
            Management Equity Incentive Plan. Your aggregate 2021 Long Term Incentive Plan (&#8220;<font style="font-family: 'Times New Roman';"><u>LTIP</u></font>&#8221;) grant, including all such grants provided pursuant to your Prior Employment Agreement, shall be
            $2,200,000. Your annual grant will be made to you at the same time that other executives of the Company receive their LTIP grants, and it will be made in a form and on terms no less favorable than LTIP grants made to other executives of the
            Company.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">9.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Employee Benefits</u></font>.&#160; You shall be eligible to participate in all employee benefit plans and arrangements, including, but not limited to, medical, dental, vision, life insurance and
            disability insurance benefits and arrangements and 401(k) plan, as are made available by the Company to its other senior executives, subject to the terms and conditions thereof. In addition, to the extent applicable, you will be entitled to
            participate in the Company&#8217;s relocation program on a basis that is no less favorable to you than any other participant (current or former) in such program.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">10.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Vacation</u></font>.&#160; You will be entitled to paid vacation and holidays pursuant to the terms of the Company&#8217;s vacation policy as may be in effect from time to time, but in no event less
            than five weeks of paid vacation per calendar year.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">11.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Financial Advisory Services</u></font>.&#160; The Company will provide you with a stipend of $10,000 annually toward the cost of personal financial advisory or tax preparation services.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Business Expenses</u></font>.&#160; You will be reimbursed for all out-of-pocket business, travel, marketing, entertainment and other similar expenses reasonably incurred in the performance of
            your duties on behalf of the Company following presentation by you of reasonable substantiation of such expenses.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">13.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Termination and Change in Control</u></font>.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z272f466231f645ccb7458fbada3285ee">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination for Any Reason</u></font><font style="font-size: 10pt;">.&#160; Upon termination of your
                  employment with the Company for any reason, you will receive payment for any unpaid Annual Base Salary through the date of termination; any Annual Bonus earned but unpaid with respect to a performance period ending on or preceding the
                  date of termination; reimbursement for any unreimbursed business expenses incurred through the date of termination; payment for any accrued but unused vacation time and sick time;&#160; and all other vested payments, benefits or fringe
                  benefits to which you may be entitled under the terms of any applicable compensation arrangement or benefit, equity or fringe benefit plan or program or grant or this Agreement (collectively the &#8220;<font style="font-family: 'Times New Roman';"><u>Accrued Benefits</u></font>&#8221;).</font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zab45f08e76514c50996fb08bcc13b6b5">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination Without Cause or Resignation for Good Reason Prior to a Change in Control</u></font><font style="font-size: 10pt;">.&#160; Except as provided in the paragraph immediately below, if your employment with the Company is terminated without Cause or you resign for Good Reason, in addition to the Accrued Benefits, the Company will pay or
                  provide you with the following: (i)(A) an aggregate dollar amount equal to the product of (x) 2.0 multiplied by (y) the sum of (I) your Annual Base Salary in effect immediately prior to your termination of employment or the occurrence of
                  Good Reason (whichever is higher) plus (II) the Target Bonus, payable in cash in equal installments over the 24 month period immediately following the date of termination of employment; (B) reimbursement (on an after-tax basis) of all of
                  your premiums for continuing your health care coverage and the coverage of your dependents who are covered at the time of your termination or resignation, under the applicable provisions of the Consolidated Omnibus Budget Reconciliation
                  Act of 1985 (COBRA) for a period ending on the earlier of the date that is eighteen (18) months after the date of termination or resignation or the date on which you become eligible to be covered by the health care plans of another
                  employer (&#8220;<font style="font-family: 'Times New Roman';"><u>COBRA Continuation</u></font>&#8221;); (C) a pro-rata portion of your Annual Bonus for the fiscal year in which your termination occurs based on actual results for such year
                  (determined by multiplying the amount of such bonus which would be due for the full fiscal year by a fraction, the numerator of which is the number of days during the fiscal year of termination that you are employed by the Company and the
                  denominator of which is 365), payable at the same time bonuses for such year are paid to other senior executives of the Company (the &#8220;<font style="font-family: 'Times New Roman';"><u>Pro-Rata Bonus</u></font>&#8221;) (collectively, &#8220;<font style="font-family: 'Times New Roman';"><u>Severance Payments</u></font>&#8221;) and (ii) with respect to any unvested equity-based incentive awards, such awards shall continue to be governed by the terms of the applicable plan and award
                  agreement under which they were granted; <font style="font-family: 'Times New Roman';"><u>provided</u></font> that, to the extent such terms or concepts are included in any such plan or award agreement, the definitions of &#8220;Cause&#8221; and
                  &#8220;Good Reason&#8221; set forth herein shall apply and control. The Company&#8217;s obligation to make Severance Payments is conditioned upon your execution and delivery of the Release (as defined herein). The Company will commence payment (or
                  reimbursement) of the Severance Payments 60 days following the date of termination of your employment, <font style="font-family: 'Times New Roman';"><u>provided</u></font> that prior to such date, the Release has become effective in
                  accordance with its terms. The first payment will include a catch-up payment covering the amount that would have otherwise been paid during the period between the date of your termination of employment and the first payment date but for
                  the application of the preceding sentence, and the balance of the installments will be payable in accordance with the schedule set forth herein. In the event of your death prior to payment in full of the Severance Payments, the Company
                  shall pay your estate the remaining unpaid Severance Payments.</font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd08cbee2b29142a4afa154c721c8a023">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">c.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination Following a Change in Control</u></font><font style="font-size: 10pt;">.&#160; If, at any
                  time during the 90 day period preceding, or 24 month period following, a Change in Control, your employment with the Company is terminated without Cause or you resign for Good Reason, in addition to the Accrued Benefits, the Company will
                  pay or provide you with the following: (i)(A) an aggregate dollar amount equal to the product of (x) 3.0 multiplied by (y) the sum of (I) your Annual Base Salary in effect immediately prior to your termination of employment or the
                  occurrence of Good Reason (whichever is higher) plus (II) the Target Bonus, payable as follows: (1) if the Change in Control is also a &#8220;change in control event&#8221; for purposes of Code Section 409A, the amount in this clause (i)(A) will be
                  paid in a single lump sum within the 60-day period following the date your employment ends (or if later, the date of such Change in Control) or (2) if the Change in Control does not constitute a &#8220;change in control event&#8221; for purposes of
                  Code Section 409A, the amount in this clause (i)(A) will be paid in equal installments over the 24 month period immediately following the date of termination of employment; (B) COBRA Continuation; (C) the Pro-Rata Bonus (collectively, &#8220;<font style="font-family: 'Times New Roman';"><u>CIC Severance Payments</u></font>&#8221;) and (ii)(A) with respect to any unvested equity-based incentive awards subject to time-based vesting, you will immediately become fully vested in, and all
                  options shall immediately become exercisable or cash or shares will be immediately settled or distributed with respect to, all such awards, and (B) with respect to any unvested equity-based incentive awards subject to performance-based
                  vesting, you will vest in, and options shall become exercisable, or cash or shares will be settled or distributed, assuming performance at target levels applicable to all such awards had been achieved (regardless of actual performance)
                  (collectively, &#8220;<font style="font-family: 'Times New Roman';"><u>CIC Equity Vesting</u></font>&#8221;). The Company&#8217;s obligation to make CIC Severance Payments or provide the CIC Equity Vesting is conditioned upon your execution and delivery of
                  the Release. To the extent any equity grant agreement or other agreement between the Company and you contains provisions accelerating the vesting of unvested equity awards upon a Change in Control (or similar term) or termination of your
                  employment without Cause or a resignation for Good Reason that are more favorable to you than the CIC Equity Vesting, then the vesting provisions of such equity grant or other agreement will govern. The Company will commence payment (or
                  reimbursement, to the extent required by Code Section 409A) of the Severance Payments 60 days following the date of termination of your employment, <font style="font-family: 'Times New Roman';"><u>provided</u></font> that prior to such
                  date, the Release has become effective in accordance with its terms. The first payment will include a catch-up payment covering the amount that would have otherwise been paid during the period between the date of your termination of
                  employment and the first payment date but for the application of the preceding sentence, and the balance of the installments will be payable in accordance with the schedule set forth herein. In the event of your death prior to payment in
                  full of the CIC Severance Payments, the Company shall pay your estate the remaining unpaid CIC Severance Payments. In no event shall you be obligated to seek other employment or take any other action by way of mitigation of the amounts
                  payable to you under any of the provisions of this Agreement, nor shall the amount of any payment hereunder be reduced by any compensation earned by you as a result of employment by a subsequent employer, except to the limited extent
                  provided with respect to COBRA Continuation.</font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">14.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>No Excise Tax Gross-Up; Possible Reduction in Parachute Payments</u></font>.&#160; Notwithstanding any restrictions set forth in any Company plan or arrangement, if any portion of your Severance
            Payments, CIC Severance Payments, Equity Vesting, CIC Equity Vesting or any other payments in the nature of compensation provided to you (each, a &#8220;<font style="font-family: 'Times New Roman';"><u>Payment</u></font>&#8221;) constitutes &#8220;parachute
            payments&#8221; within the meaning of Section 280G of the Code and, but for this subsection, would be subject to the excise tax imposed by Section 4999 of the Code (the &#8220;<font style="font-family: 'Times New Roman';"><u>Excise Tax</u></font>&#8221;), then
            your Payments will be payable either in full or in such lesser amount as would result, after taking into account the applicable federal, state and local income taxes and the Excise Tax, in your receipt on an after-tax basis of the greater
            amount of Payments. Any reduction in the Payments pursuant to the preceding sentence shall be effected first by reducing or eliminating Severance Payments or CIC Severance Payments, as applicable, and then by reducing or eliminating the Equity
            Vesting or CIC Equity Vesting, and then by reducing other compensation and benefits. Such reductions shall be allocated pro rata between amounts that are subject to Section 409A of the Code and amounts that are not subject to Section 409A of
            the Code. Any determination required under this section shall be made in writing by the Company&#8217;s independent public accountants (the &#8220;<font style="font-family: 'Times New Roman';"><u>Accountants</u></font>&#8221;), whose determination shall be
            conclusive and binding upon you and the Company for all purposes. For purposes of making the calculations required by this section, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on
            reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and you shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to
            make a determination under this section. The Company shall bear all costs and fees of the Accountants in connection with any calculations contemplated by this section. No less than five days prior to a change in ownership, the Company shall
            provide you, or permit the Accountants to provide you, with all calculations and supporting documentation related to the determination of the Excise Tax. The Company&#8217;s obligations under this section shall survive your termination of employment.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">15.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Indemnification</u></font>.&#160; If you are made or threatened to be made a party to or a participant in any actual, threatened, pending, or completed action, claim, or proceeding of any type,
            the Company shall indemnify, defend, and hold you harmless to the fullest extent authorized or permitted by applicable law, by its Certificate of Incorporation, and by its By-Laws, as the foregoing may be amended from time to time, and
            including any and all expenses (including, without limitation, advancement and payment of attorneys&#8217; fees) and losses arising out of or relating to any of your actual or alleged acts, omissions, negligence or active or passive wrongdoing,
            including the advancement of expenses you incur. In addition, without limiting the foregoing, the Company shall provide you with indemnification protection under any separate written indemnification agreement entered into with executives and
            directors of the Company on terms no less favorable than provided to any other Company executive officer or director. Further, in the event you prevail on any material issue in connection with any controversy, dispute or claim which arises out
            of or relates to this Agreement, any other agreement or arrangement between you and the Company, your employment with the Company, or the termination thereof, then the Company shall reimburse you (and your beneficiaries) for any and all costs
            and expenses (including without limitation attorneys&#8217; fees) incurred by you (or any of your beneficiaries) in connection with such controversy, dispute or claim. In addition, during your employment with the Company and while potential liability
            exists (but in no event less than six years thereafter), the Company or any successor to the Company shall purchase and maintain, at its own expense, directors&#8217; and officers&#8217; liability insurance providing coverage to you on terms that are no
            less favorable than the coverage provided to other directors and officers of Company.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">16.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Confidential Information; Work Product</u></font>.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5b09e0dd579e4274966b46683473fb54">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Definition of Confidential Information</u></font><font style="font-size: 10pt;">.&#160; As used in this
                  Agreement, &#8220;<font style="font-family: 'Times New Roman';"><u>Confidential Information</u></font>&#8221; includes, but is not limited to, any type of trade secret or other information, whether in hard-copy or electronic format or communicated
                  orally, relating to the business of the Company that you acquire or have acquired through employment with the Company, and that has value such that the Company designates or treats the information as confidential through its policies,
                  procedures and/or practices. Confidential Information is limited to information that is not generally known to competitors or that is not in the public domain through lawful means. Confidential Information does not include information
                  that has been voluntarily disclosed to the public by the Company (except where such public disclosure has been made in breach of a duty of confidentiality); information known to you prior to first receipt of or access to such information
                  in the course of your employment with the Company; or information that has been independently developed and disclosed by, or rightfully received by you outside the course of your employment with the Company from, a third party who does
                  not owe the Company, as applicable, a duty of confidentiality with respect to such information. Subject to the foregoing, examples of Confidential Information include, without limitation, the following: (i) any files, lists or other
                  information relating to customers; (ii) non-published pricing and financial information and data; (iii) strategic, marketing and research information including, without limitation, business plans, strategies and market research data; (iv)
                  technical information including, without limitation, software, source code, object code and other non-public intellectual property; and (v) product research and development including, without limitation, testing data, formulas, products
                  in development and all other research data.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z40c996a83eec481ba786e5796cb157dd">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Non-Disclosure of Confidential Information</u></font><font style="font-size: 10pt;">.&#160; You
                  acknowledge that the Company has spent considerable time, effort and expense developing its Confidential Information and has taken reasonable measures to protect its secrecy. You therefore acknowledge and agree that you will not, except
                  in the normal course of your duties on behalf of the Company, disclose or use, or enable anyone else to disclose or use, either during your employment with the Company or at any time subsequent thereto, any Confidential Information
                  without prior written approval from the Company.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z03aaa2203a7f49088b52cfd5a1b2b814">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">c.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Return of Company Property</u></font><font style="font-size: 10pt;">.&#160; You agree that all
                  documents and other materials of any kind pertaining to the business of the Company (including Confidential Information in any format) in your possession at any time during your employment are and shall be the property of the Company and
                  that all such property, including all copies thereof and all such information contained on your personal computer(s), your personal smart phone, your other personal devices, or any other storage devices (electronic or otherwise) shall be
                  surrendered by you to the Company upon the Company&#8217;s request from time to time during your employment, and with or without request upon, or within a reasonable period following, the termination of your employment.</font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">17.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Ownership of Property</u></font>.&#160; You acknowledge that all discoveries, concepts, ideas, inventions, innovations, improvements, developments, methods, processes, programs, designs,
            analyses, drawings, reports, patent applications, copyrightable work and mask work (whether or not including any confidential information) and all registrations or applications related thereto, all other proprietary information and all similar
            or related information (whether or not patentable) that relate to the Company&#8217;s actual or anticipated business, research and development, or existing or future products or services and that are conceived, developed, contributed to, made or
            reduced to practice by you (either solely or jointly with others) while employed by the Company (including any of the foregoing that constitutes any proprietary information or records) (&#8220;<font style="font-family: 'Times New Roman';"><u>Work
                Product</u></font>&#8221;) belong to the Company and you hereby assign, and agree to assign, all of the above Work Product to the Company. Any copyrightable work prepared in whole or in part by you in the course of your work for any of the
            foregoing entities shall be deemed a &#8220;work made for hire&#8221; under the copyright laws and the Company shall own all rights therein. To the extent that any such copyrightable work is not a &#8220;work made for hire,&#8221; you hereby assign and agree to assign
            to the Company all right, title, and interest, including without limitation, copyright in and to such copyrightable work. You understand, however, that there is no obligation being imposed on you to assign any invention falling within the
            definition of Work Product for which no equipment, supplies, facility, or trade secret information of the Company was used and that was developed entirely on your own time, unless (i) such Work Product relates (a) to the Company&#8217;s businesses or
            (b) to the Company&#8217;s actual or demonstrably anticipated research or development, or (ii) the Work Product results from any work performed by you under this Agreement.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">18.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Non-Disparagement</u></font>.&#160; You agree that you will not at any time make, publish or communicate to any person or entity or in any public forum any defamatory or disparaging remarks,
            comments, or statements concerning the Company, other than in the performance of your duties for the Company. The Company and its respective officers and directors, respectively, agree that it and they will not at any time make, publish or
            communicate to any person or entity or in any public forum any defamatory or disparaging remarks, comments, or statements concerning you. The foregoing shall not be violated by truthful statements in response to legal process, required
            governmental testimony or filings, or administrative or arbitral proceedings (including, without limitation, depositions in connection with such proceedings).</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">19.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Non-Competition</u></font>.&#160; You covenant and agree that at all times during your employment by the Company and for a period of 24 months following termination of your employment for any
            reason or no reason, you shall not, directly or indirectly, individually or jointly, own any interest in, operate, or participate as a partner, advisor, board member, director, principal, officer or agent of, enter into the employment of, act
            as a consultant to, or perform any services for any person or entity (other than the Company), that engages in the Business in the Restricted Area (as those terms are defined herein). Notwithstanding anything herein to the contrary, this
            section shall not prevent you from owning not more than five percent (5%) in the aggregate of any class of equity of any company if such equity is publicly traded and listed on any national or regional stock exchange. In addition, the
            provisions of this section shall not be violated by you commencing employment with a subsidiary, division or unit of any entity that engages in the Business so long as you and such subsidiary, division or unit do not engage in the Business.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">20.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Non-Solicitation</u></font>.&#160; During your employment by the Company and for a period of 24 months following termination of your employment for any reason or no reason: (a) you, except as
            part of your duties to the Company, shall not directly or indirectly, for your own benefit or on behalf of any other person or entity, for the purpose of entering into a Restricted Transaction, solicit, call on, service or enter into any
            agreement with any customer with whom the Company did any business within the 12 month period preceding the termination of your employment with the Company, and with whom you had contact for the purpose of a Restricted Transaction, for whom you
            had supervisory responsibility or about whom you had access to and used Confidential Information; (b) you shall not, directly or indirectly, for your own benefit or on behalf of any other person or entity, solicit, induce or encourage any
            employee of the Company with whom you had material contact to leave such employee&#8217;s employment with the Company or to cease such employee&#8217;s relationship with the Company; and (c) you shall not, directly or indirectly, for your own benefit or on
            behalf of any other person or entity encourage (or assist another in encouraging) any supplier, business partner, or vendor of the Company with whom you had any contact on behalf of the Company within the last 12 months of your employment with
            the Company to terminate or diminish its relationship with the Company. For purposes of this section, &#8220;<font style="font-family: 'Times New Roman';"><u>Restricted Transaction</u></font>&#8221; means the marketing, selling and/or providing of products
            or services of the type marketed, sold, actively developed or provided by the Company during the 12 month period prior to the termination of your employment. Notwithstanding the foregoing, the provisions of this section shall not be violated by
            (a) general advertising or solicitation not specifically targeted at Company-related persons or entities, (b) you serving as a reference, upon request, for any employee of the Company, or (c) actions taken by any person or entity with which you
            are associated if you are not personally involved in any manner in the matter and have not identified such Company-related person or entity for soliciting or hiring.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">21.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Enforcement</u></font>.&#160; You agree and acknowledge that the Restrictive Covenant Provisions do not preclude you from earning a livelihood, nor do they unreasonably impose limitations on your
            ability to earn a living. You acknowledge that you have carefully read this Agreement and have given careful consideration to the restraints imposed on you by this Agreement, and you are in full accord as to their necessity for the reasonable
            and proper protection of confidential and proprietary information of the Company now existing or to be developed in the future. You expressly acknowledge and agree that each and every restraint imposed by this agreement is reasonable with
            respect to subject matter, time period and geographical area. In the event you breach any provision hereof, the Company shall be entitled to entry of an injunction prohibiting the same, in addition to any other remedy or relief that may be
            available to the Company at law or in equity. If you breach any provision herein, the time periods relating to the restrictions in the Restrictive Covenant Provisions shall be extended for a period of time equal to that period of time during
            which you are determined to be in breach.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">22.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Definitions</u></font>.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf35db32d78da448a9ba6e6f06006b761">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Business</u></font>&#8221; means the business of (i) developing, acquiring, managing, producing, marketing, providing and selling
                titanium ore and titanium dioxide and (ii) mining and beneficiating mineral sands.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2bb2d602c7a445378d17937e8b21967c">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Cause</u></font>&#8221; means (i) the arrest, indictment, conviction or plea of guilty or no contest for any felony or any
                misdemeanor involving acts of dishonesty or moral turpitude which in the estimation of the Board, acting reasonably, would disqualify you from serving as an executive officer of the Company; (ii) the willful commission of an act involving
                misappropriation, embezzlement or fraud which involves a material matter with respect to the Company or any of its customers or suppliers; (iii) substantial and repeated failure to perform duties of the office you hold as reasonably
                directed by the Board; (iv) gross negligence or willful misconduct with respect to the Company that is or could reasonably be expected to be harmful to the Company in any material respect; (v) willful conduct bringing the Company into
                substantial public disgrace or disrepute, and (vi) any material breach by you of this Agreement or any of the Company&#8217;s material policies. Any determination of Cause by the Company will be made by a resolution approved by a two-thirds
                majority of the members of the Board, <font style="font-family: 'Times New Roman';"><u>provided</u></font> that no such determination of Cause may be made until you have been given written notice detailing the specific Cause event (which
                such notice must be provided to you within 30 days of the occurrence of the alleged event constituting Cause), and you have been given a period of at least 30 days following receipt of such notice to cure such event (if susceptible to
                cure). To the extent an event is not so cured or deemed not susceptible to cure, the Board shall provide you with an opportunity on at least ten days advance written notice to appear (with legal counsel) before the full Board to discuss the
                specific circumstances alleged to constitute a Cause event. For purposes of this definition, an act, or a failure to act, shall not be deemed willful or intentional, as those terms are defined herein, unless it is done, or omitted to be
                done, by you in bad faith or without a reasonable belief that your action or omission was in the best interest of the Company.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z46bff603a39649f8a95171980d9fbde8">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">c.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Change in Control</u></font>&#8221; means a &#8220;Change of Control&#8221; as that term is defined in the Tronox Holdings plc Management Equity
                Incentive Plan, as amended, as in effect on the date hereof.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc2bcf7eee7c744be9520d89379719ecc">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">d.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Code</u></font>&#8221; means the Internal Revenue Code of 1986, as amended.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z09baa1db8825463ba6bbb4edbbc9a223">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">e.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Good Reason</u></font>&#8221; means (i) a reduction in your Annual Base Salary, (ii) a diminution in your title or a diminution in
                your duties or responsibilities inconsistent with your position including without limitation being asked to resign as a member from the Company&#8217;s Board of Directors (but, excluding an individual event resulting in a de minimis diminution in
                your duties or responsibilities), provided, however, that if you provide notice of resignation after such a diminution in your title, duties or responsibilities, you agree to provide the Company with continued service in a professional and
                capable manner for a period of up to six months after such notice (although such period may be reduced in the discretion of the Company), (iii) a material breach of this Agreement by the Company or a material breach by the Company of
                another material agreement between you and the Company, or (iv) the failure of the Company to obtain the assumption (by operation of law, the continuation of the corporate existence of the Company or otherwise) of this Agreement or
                substitution of a substantially similar agreement by any successors in a Change of Control, in each case without your prior written consent; <font style="font-family: 'Times New Roman';"><u>provided</u></font> that you must deliver written
                notice of your resignation to the Company within 90 days of your actual knowledge of any such event, the Company must be provided at least 30 days during which it may remedy the condition and you must terminate your employment within six
                months of the initial occurrence of Good Reason in order for such resignation to be with Good Reason for any purpose hereunder (except as set forth in (ii) above).</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zda7a082302fb4dcc9344a3dfc04c0cf9">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">f.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Person</u></font>&#8221; means an individual, a partnership, a limited liability company, a corporation, an association, a joint
                stock company, a trust, a joint venture, an unincorporated organization, investment fund, any other business entity and a governmental entity or any department, agency or political subdivision thereof.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb2923254074c432b967e90fcb38d08e7">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">g.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Release</u></font>&#8221; means an agreement executed by you in a form mutually agreeable between you and the Company that contains:
                (i) an acknowledgement by the Company that it does not know (upon reasonable diligence) of any claims against you and (ii) a general release and waiver by you of any and all claims against the Company; <font style="font-family: 'Times New Roman';"><u>provided</u></font> that the Release shall specifically exclude: (a) any right to the benefits, including, without limitation, any severance benefits, to which you are entitled under this Agreement, (b) any claim relating to
                directors&#8217; and officers&#8217; liability insurance coverage or any right of indemnification under the Company&#8217;s or its affiliates&#8217; organizational documents, applicable law or otherwise, (c) any rights you may have as a member or holder of equity
                or other securities of the Company or its affiliates, and (d) any rights or entitlements under any applicable sale or transaction agreement. For the sake of clarity, the Company may require that you re-affirm in the Release the Restrictive
                Covenants set forth herein, but the Company may not impose additional restrictive covenants on you.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9a5f33f5b84f434a996c2bed24f935bf">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">h.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Restricted Area</u></font>&#8221; means each country throughout the world in which the Company conducts the Business.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z38092e142b934f1ebcb6712d051d607c">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">i.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Restrictive Covenants</u></font>&#8221; means, collectively, the sections of this Agreement captioned &#8220;Confidential Information;
                Work Product;&#8221; &#8220;Ownership of Property;&#8221; &#8220;Non-Disparagement;&#8221; &#8220;Non-Competition;&#8221; and &#8220;Non-Solicitation.&#8221;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb1a8234c70614c149148993bb2fc7ee2">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">j.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Subsidiary</u></font>&#8221; means, with respect to any Person, any corporation, limited liability company, partnership,
                association, or business entity of which (i) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers, or
                trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (ii) if a limited liability company, partnership, association,
                or other business entity (other than a corporation), a majority of partnership or other similar ownership interest thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person
                or a combination thereof. For purposes hereof, a Person or Persons shall be deemed to have a majority ownership interest in a limited liability company, partnership, association, or other business entity (other than a corporation) if such
                Person or Persons shall be allocated a majority of limited liability company, partnership, association, or other business entity gains or losses or shall be or control any managing director or general partner of such limited liability
                company, partnership, association, or other business entity.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">23.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Compensation Recovery (Clawback)</u></font>.&#160; Any amounts of compensation paid or awarded to you under this Agreement shall be subject to compensation recovery (clawback) to the extent
            required by applicable law or regulations in the event the Company is required to prepare an accounting restatement due to the material noncompliance of the Company with any financial reporting requirements under the securities laws and the
            amounts received based on erroneous data was in excess of what would have been received by you had such noncompliance not occurred.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">24.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Representations</u></font>.&#160; You hereby represent to the Company that (a) you have the legal right to enter into this Agreement and to perform all of the obligations on your part to be
            performed hereunder in accordance with its terms, and (b) you are not a party to any agreement or understanding, written or oral, and are not subject to any restriction, which, in either case, could prevent you from entering into this Agreement
            or performing your duties and obligations hereunder.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">25.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Arbitration</u></font>.&#160; The parties agree that any controversy or claim arising out of or relating to this Agreement, or the alleged breach thereof, shall be submitted for resolution to the
            American Arbitration Association (&#8220;<font style="font-family: 'Times New Roman';"><u>AAA</u></font>&#8221;) and that three (3) neutral arbitrators will be selected to adjudicate such controversy or claim in a manner consistent with the AAA Employment
            Arbitration Rules then in effect (the &#8220;<font style="font-family: 'Times New Roman';"><u>Rules</u></font>&#8221;). The arbitration proceedings will allow for discovery according to the Rules.&#160; All arbitration proceedings shall be conducted in Oklahoma
            City, Oklahoma. The parties are entitled to representation by an attorney or other representative of their choosing. The Company shall bear the costs of the arbitration filing and hearing fees and the cost of the arbitrators. Such arbitration
            shall be the sole, exclusive and final remedy for any dispute between you and the Company relating to this Agreement, the employment relationship between you and the Company and any disputes upon termination of employment, other than claims for
            workers&#8217; compensation, unemployment insurance benefits, or alleged or threatened breaches of any of the Restrictive Covenants. <font style="font-family: 'Times New Roman'; font-weight: bold;">Accordingly, you and the Company each acknowledges
              and agrees that each is waiving all respective rights to file an action in court or to receive a trial by jury with respect to any and all claims that are subject to arbitration as set forth herein.</font> Either party may exercise the right
            to arbitrate by providing the other party with written notice of any and all claims forming the basis of such right in sufficient detail to inform the other party of the substance of such claims. Notwithstanding the foregoing, in the event you
            breach or threaten to breach any of the Restrictive Covenants, the Company shall be entitled to entry of an injunction prohibiting same, in addition to any other remedy or relief that may be available to Company at law or in equity. In the
            event of a breach or threatened breach of any such Restrictive Covenant, you agree that, in addition to any other remedies available at law or equity, the Company may file litigation against you seeking specific performance and temporary and/or
            preliminary injunctive relief, enjoining or restraining such breach or threatened breach, and you consent to the issuance of such injunctive relief without bond. You also agree that any action seeking such injunctive or equitable relief may be
            filed in any state or federal court located within Oklahoma and that you shall be subject to personal jurisdiction in any such court.&#160; Notwithstanding anything set forth herein, the parties&#8217; arbitration agreement set forth in this section shall
            expire immediately following a Change in Control.&#160; Following the arbitration expiration date, the parties agree that any controversy or claim arising out of or relating to this Agreement, or breach thereof, shall be submitted for resolution
            only to the state or federal courts located within Oklahoma.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">26.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Code Section 409A</u></font>.&#160; This Agreement is intended to comply with Section 409A or an exemption thereunder and shall be construed and administered in accordance with Section 409A.
            Notwithstanding any other provision of this Agreement, payments provided under this Agreement may only be made in a manner that complies with Section 409A or an applicable exemption. Any payments under this Agreement that may be excluded from
            Section 409A either as separation pay due to an involuntary separation from service or as a short-term deferral shall be excluded from Section 409A to the maximum extent possible. For purposes of Section 409A, each installment payment provided
            under this Agreement shall be treated as a separate payment. Any payments to be made under this Agreement upon a termination of employment that are considered &#8220;nonqualified deferred compensation&#8221; for purposes of Section 409A shall only be made
            upon a &#8220;separation from service&#8221; under Section 409A. Notwithstanding any other provision of this Agreement, if any payment or benefit provided to you in connection with your termination of employment is determined to constitute &#8220;nonqualified
            deferred compensation&#8221; within the meaning of Section 409A and you are determined to be a &#8220;specified employee&#8221; as defined in Section 409A(a)(2)(b)(i), then such payment or benefit shall not be paid until the first payroll date to occur following
            the six-month anniversary of the date of your termination of employment or, if earlier, on your death (the &#8220;<font style="font-family: 'Times New Roman';"><u>Specified Employee Payment Date</u></font>&#8221;). The aggregate of any payments that would
            otherwise have been paid before the Specified Employee Payment Date and interest on such amounts calculated based on the applicable federal rate published by the Internal Revenue Service for the month of your termination of employment shall be
            paid to you in a lump sum on the Specified Employee Payment Date and thereafter, any remaining payments shall be paid without delay in accordance with their original schedule. To the extent required by Section 409A, each reimbursement or
            in-kind benefit provided under this Agreement shall be provided in accordance with the following (a) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during each calendar year cannot affect the expenses eligible
            for reimbursement, or in-kind benefits to be provided, in any other calendar year; (b) any reimbursement of an eligible expense shall be paid to you on or before the last day of the calendar year following the calendar year in which the expense
            was incurred; and (c) any right to reimbursements or in-kind benefits under this Agreement shall not be subject to liquidation or exchange for another benefit.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">27.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Severability</u></font>.&#160; In the event that any part or provision of this Agreement shall be held to be invalid or unenforceable by any arbitrator or court of competent jurisdiction, the
            remaining provisions thereof shall nevertheless continue to be valid and enforceable as though the invalid or unenforceable part or provision had not been included therein. Further, in the event that any part or provision hereof shall be
            declared by a court of competent jurisdiction to exceed the maximum time period, scope or activity restriction that such court deems reasonable and enforceable, then the parties expressly authorize the court to modify such part or provision so
            that it may be enforced to the maximum extent permitted by law.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">28.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>No Waiver</u></font>.&#160; The failure by either party at any time to require performance or compliance by the other of any of its obligations or agreements shall in no way affect the right to
            require such performance or compliance at any time thereafter. The waiver by either party of a breach of any provision hereof shall not be taken or held to be a waiver of any preceding or succeeding breach of such provision or as a waiver of
            the provision itself. No waiver of any kind shall be effective or binding, unless it is in writing and is signed by the party against whom such waiver is sought to be enforced.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">29.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Assignment</u></font>.&#160; This Agreement and all rights hereunder are personal to you and may not be transferred or assigned by you at any time. The Company may assign its rights, together
            with its obligations hereunder, to any parent, subsidiary or successor, or in connection with any sale, transfer or other disposition of all or substantially all of its business and assets provided, however, that any such assignee assumes the
            Company&#8217;s obligations hereunder.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">30.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Tax Withholding and Equalization</u></font>.&#160; All sums payable to you hereunder shall be reduced by all federal, state, local and other withholding and similar taxes and payments required by
            applicable law.&#160; The Company will tax equalize you for any personal income taxes in the United Kingdom that become due and payable from you in connection with business conducted in the United Kingdom due to your executive and/or Board
            activities on behalf of the Company.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">31.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Entire Agreement</u></font>.&#160; This Agreement constitutes the entire and only agreement and understanding between the parties relating to your employment with the Company. This Agreement
            supersedes any and all previous contracts, arrangements or understandings with respect to your employment with the Company, including the Prior Employment Agreement.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">32.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Amendment</u></font>.&#160; The parties understand and agree that this Agreement may not be amended, modified or waived, in whole or in part, except in a writing executed by you and the Chair of
            the Board or the Lead Director as the case may be.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">33.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Notices</u></font>.&#160; All notices, if any, and all other communications, if any, required or permitted under this Agreement shall be in writing and hand delivered, sent via facsimile, sent by
            registered first class mail, postage pre-paid, or sent by nationally recognized express courier service. Such notices and other communications shall be effective upon receipt if hand delivered or sent via facsimile, five (5) days after mailing
            if sent by mail, and one (1) day after dispatch if sent by express courier, to the following addresses, or such other addresses as any party shall notify the other parties:</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; margin-left: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If to the Company:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; margin-left: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tronox Holdings plc</div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">One Stamford Plaza</div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">263 Tresser Boulevard, Suite 1100</div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Stamford, Connecticut 06901</div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Attention: General Counsel</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If to you:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">John D. Romano</div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Contact information on file.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">34.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Counterparts</u></font>.&#160; This Agreement may be executed in multiple counterparts and delivered by facsimile or electronic (.pdf or .tiff) signature, each of which shall be considered an
            original and all of which, when taken together, shall be considered a single agreement.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">35.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Governing Law</u></font>.&#160; This Agreement and the rights and obligations of the parties hereto shall be construed in accordance with the laws of the State of Connecticut, without giving
            effect to the principles of conflict of laws.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Company and you have executed this Agreement as of the date set forth below.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">ACCEPTED and AGREED to by</font><font style="font-size: 10pt;">:</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0205d81c6ede4a91a7d26117dec70f16">

          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">TRONOX HOLDINGS PLC</div>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">EXECUTIVE</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:&#160; <u><font style="font-family: 'Times New Roman';">/s/ Ilan Kaufthal</font></u></div>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:&#160; <u><font style="font-family: 'Times New Roman';">/s/ </font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">John D. Romano</font></u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><br>
              </div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">Ilan Kaufthal</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">John D. Romano</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><br>
              </div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">Chair of the Board</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Date: March 18, 2021</div>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Date: March 18, 2021</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>brhc10021910_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Execution Version<br>
        <br>
      </div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-weight: bold;">Exhibit 10.3</font></div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-weight: bold; font-size: 10pt;"></font><font style="font-size: 10pt;"><br>
        </font></div>
    </div>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CO-CHIEF EXECUTIVE OFFICER</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EMPLOYMENT AGREEMENT</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; margin-right: 3.6pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">This CO-CHIEF EXECUTIVE OFFICER EMPLOYMENT AGREEMENT (the &#8220;<font style="font-family: 'Times New Roman';"><u>Agreement</u></font>&#8221;)

        is entered into as of this 18th day of March 2021 (the &#8220;<font style="font-family: 'Times New Roman';"><u>Effective Date</u></font>&#8221;) by and between Tronox Holdings plc (together with its successors and assigns, the &#8220;<font style="font-family: 'Times New Roman';"><u>Company</u></font>&#8221;), and Jean Fran&#231;ois Turgeon, an individual (the &#8220;<font style="font-family: 'Times New Roman';"><u>Executive</u></font>&#8221; or &#8220;<font style="font-family: 'Times New Roman';"><u>you</u></font>&#8221;).</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; margin-right: 3.6pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, you are currently employed as the Interim Co-Chief Executive Officer of the Company pursuant to a
        Letter Appointment dated December 27, 2020 and an Employment Agreement dated July 25, 2013 that was extended dated July 13, 2016 (collectively the &#8220;<font style="font-family: 'Times New Roman';"><u>Prior Employment Agreement</u></font>&#8221;); and</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; margin-right: 3.6pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, you and the Company desire to terminate the Prior Employment Agreement and to enter into this
        Agreement to set out the terms and conditions for the continued employment relationship between you and the Company.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; margin-right: 3.6pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein and for other good
        and valuable consideration, the receipt and sufficiency of which hereby are acknowledged, the parties hereto agree as follows:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Start Date</u></font>.&#160; Your new position with the Company as described in this Agreement will be effective as of the Effective Date.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Place of Employment</u></font>.&#160; During your employment pursuant to this Agreement, you may maintain your personal residence at a location of your own choice and work from such location, <font style="font-family: 'Times New Roman';"><u>provided</u></font> that:&#160; (i) you are present at the Company&#8217;s corporate headquarters, currently located at One Stamford Plaza, 263 Tresser Boulevard, Stamford, Connecticut 06901 (the &#8220;Corporate
            Headquarters&#8221;), and/or at the Company&#8217;s offices in New York City (the &#8220;NYC Office&#8221;), as necessary or advisable to effectively manage and execute the business of the Company; and (ii) subject to paragraph 31, you bear all responsibility for
            personal income taxes in connection with your personal residence decisions.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Position and Duties</u></font>.&#160; You will be employed by the Company as its Co-Chief Executive Officer, and together with the other Co-Chief Executive Officer, you will serve as the most
            senior executive officers of the Company, reporting directly to the Board of Directors of the Company (the &#8220;<font style="font-family: 'Times New Roman';"><u>Board</u></font>&#8221;). You will have the normal duties, responsibilities and authority
            implied by such position, subject to the power of the Board to expand such duties or limit such duties (subject to your rights as set forth in this Agreement, including your right to resign for Good Reason as set forth herein).&#160; The Board will
            elect you as a member of the Board as soon as it can do so subject to ensuring that a majority of the members of the Board meet the independence rules of the New York Stock Exchange.&#160; In addition, the Company and the Board shall take such
            action as may be necessary or appropriate to nominate you for re-election as a member of the Board at the expiration of the then current term. Notwithstanding the foregoing, if you are requested to resign from the Board at any time, you agree
            to do so immediately upon receiving such a written request from the Chair of the Board or the Lead Director as the case may be.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%- % - %-->
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Exclusive Service</u></font>.&#160; You will devote your work time, efforts and attention to the business and affairs of the Company; <font style="font-family: 'Times New Roman';"><u>provided</u></font>
            that you may serve on the boards of directors of philanthropic or civic organizations and on the board of directors of one for-profit company; <font style="font-family: 'Times New Roman';"><u>provided</u></font> such service or participation
            does not interfere with your employment or duties under this Agreement and that you have advised the Board prior to commencing and the Board has consented in writing (which consent shall not be unreasonably withheld or delayed) to such outside
            activities.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">5.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Termination of Prior Employment Agreement</u></font>.&#160; Upon the Effective Date of this Agreement, it shall supersede and replace your Prior Employment Agreement, which shall be of no further
            force or effect.&#160; Notwithstanding the foregoing, within ten (10) business days of the Effective Date, the Company shall pay you the one-time special bonus of $500,000 as set forth in paragraph (b) of your Letter Appointment dated December 27,
            2020.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">6.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Base Salary</u></font>.&#160; During your employment pursuant to this Agreement, the Company will pay you a base salary at a rate of no less than $900,000/year, which amount may be increased (but
            not decreased) from time to time by the Human Resources and Compensation Committee of the Board (the &#8220;<font style="font-family: 'Times New Roman';"><u>HRCC</u></font>&#8221;) (the annual base salary as increased from time to time, the &#8220;<font style="font-family: 'Times New Roman';"><u>Annual Base Salary</u></font>&#8221;). The Annual Base Salary will be payable in accordance with the Company&#8217;s normal payroll practices, with such deductions and withholdings as are required by law.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">7.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Bonus</u></font>.&#160; During your employment pursuant to this Agreement, you will be eligible to receive a cash bonus under the Company&#8217;s Annual Incentive Plan (&#8220;<font style="font-family: 'Times New Roman';"><u>AIP</u></font>&#8221;) or other similar bonus plan adopted by the Board or the HRCC (an &#8220;<font style="font-family: 'Times New Roman';"><u>Annual Bonus</u></font>&#8221;) in an amount targeted on an annual basis at no less than 100%
            of your Annual Base Salary (or such higher amount for any fiscal year as may be determined by the HRCC from time to time) (the &#8220;<font style="font-family: 'Times New Roman';"><u>Target Bonus</u></font>&#8221;), with a maximum Annual Bonus opportunity
            of up to 200% of the Target Bonus, in each case, based upon your and/or the Company&#8217;s attainment of one or more objective performance criteria established in writing by the Board or HRCC. The Company will pay your Annual Bonus, if any, in the
            year following the year to which such Annual Bonus relates at the same time such AIP bonuses are paid to similarly situated executives of the Company.&#160; If terminated for Cause, the Annual Bonus shall not be deemed to be earned until the date on
            which it is paid by the Company.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">8.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Long-Term Incentive Compensation</u></font>.&#160; During your employment pursuant to this Agreement, you will be eligible to receive an annual grant of long-term compensation under the Company&#8217;s
            Management Equity Incentive Plan. Your aggregate 2021 Long Term Incentive Plan (&#8220;<font style="font-family: 'Times New Roman';"><u>LTIP</u></font>&#8221;) grant, including all such grants provided pursuant to your Prior Employment Agreement, shall be
            $2,200,000. Your annual grant will be made to you at the same time that other executives of the Company receive their LTIP grants, and it will be made in a form and on terms no less favorable than LTIP grants made to other executives of the
            Company.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 2 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">9.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Employee Benefits</u></font>.&#160; You shall be eligible to participate in all employee benefit plans and arrangements, including, but not limited to, medical, dental, vision, life insurance and
            disability insurance benefits and arrangements and 401(k) plan, as are made available by the Company to its other senior executives, subject to the terms and conditions thereof. In addition, to the extent applicable, you will be entitled to
            participate in the Company&#8217;s relocation program on a basis that is no less favorable to you than any other participant (current or former) in such program.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">10.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Vacation</u></font>.&#160; You will be entitled to paid vacation and holidays pursuant to the terms of the Company&#8217;s vacation policy as may be in effect from time to time, but in no event less
            than five weeks of paid vacation per calendar year.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">11.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Financial Advisory Services</u></font>.&#160; The Company will provide you with a stipend of $10,000 annually toward the cost of personal financial advisory or tax preparation services.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Business Expenses</u></font>.&#160; You will be reimbursed for all out-of-pocket business, travel, marketing, entertainment and other similar expenses reasonably incurred in the performance of
            your duties on behalf of the Company following presentation by you of reasonable substantiation of such expenses.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">13.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Termination and Change in Control</u></font>.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z27463e8d1e184b6cb707f248120100a7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination for Any Reason</u></font><font style="font-size: 10pt;">.&#160; Upon termination of your
                  employment with the Company for any reason, you will receive payment for any unpaid Annual Base Salary through the date of termination; any Annual Bonus earned but unpaid with respect to a performance period ending on or preceding the
                  date of termination; reimbursement for any unreimbursed business expenses incurred through the date of termination; payment for any accrued but unused vacation time and sick time;&#160; and all other vested payments, benefits or fringe
                  benefits to which you may be entitled under the terms of any applicable compensation arrangement or benefit, equity or fringe benefit plan or program or grant or this Agreement (collectively the &#8220;<font style="font-family: 'Times New Roman';"><u>Accrued Benefits</u></font>&#8221;).</font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 3 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z280c3a74ee9f4e378ca63ecf849ae04e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination Without Cause or Resignation for Good Reason Prior to a Change in Control</u></font><font style="font-size: 10pt;">.&#160; Except as provided in the paragraph immediately below, if your employment with the Company is terminated without Cause or you resign for Good Reason, in addition to the Accrued Benefits, the Company will pay or
                  provide you with the following: (i)(A) an aggregate dollar amount equal to the product of (x) 2.0 multiplied by (y) the sum of (I) your Annual Base Salary in effect immediately prior to your termination of employment or the occurrence of
                  Good Reason (whichever is higher) plus (II) the Target Bonus, payable in cash in equal installments over the 24 month period immediately following the date of termination of employment; (B) reimbursement (on an after-tax basis) of all of
                  your premiums for continuing your health care coverage and the coverage of your dependents who are covered at the time of your termination or resignation, under the applicable provisions of the Consolidated Omnibus Budget Reconciliation
                  Act of 1985 (COBRA) for a period ending on the earlier of the date that is eighteen (18) months after the date of termination or resignation or the date on which you become eligible to be covered by the health care plans of another
                  employer (&#8220;<font style="font-family: 'Times New Roman';"><u>COBRA Continuation</u></font>&#8221;); (C) a pro-rata portion of your Annual Bonus for the fiscal year in which your termination occurs based on actual results for such year
                  (determined by multiplying the amount of such bonus which would be due for the full fiscal year by a fraction, the numerator of which is the number of days during the fiscal year of termination that you are employed by the Company and the
                  denominator of which is 365), payable at the same time bonuses for such year are paid to other senior executives of the Company (the &#8220;<font style="font-family: 'Times New Roman';"><u>Pro-Rata Bonus</u></font>&#8221;) (collectively, &#8220;<font style="font-family: 'Times New Roman';"><u>Severance Payments</u></font>&#8221;) and (ii) with respect to any unvested equity-based incentive awards, such awards shall continue to be governed by the terms of the applicable plan and award
                  agreement under which they were granted; <font style="font-family: 'Times New Roman';"><u>provided</u></font> that, to the extent such terms or concepts are included in any such plan or award agreement, the definitions of &#8220;Cause&#8221; and
                  &#8220;Good Reason&#8221; set forth herein shall apply and control. The Company&#8217;s obligation to make Severance Payments is conditioned upon your execution and delivery of the Release (as defined herein). The Company will commence payment (or
                  reimbursement) of the Severance Payments 60 days following the date of termination of your employment, <font style="font-family: 'Times New Roman';"><u>provided</u></font> that prior to such date, the Release has become effective in
                  accordance with its terms. The first payment will include a catch-up payment covering the amount that would have otherwise been paid during the period between the date of your termination of employment and the first payment date but for
                  the application of the preceding sentence, and the balance of the installments will be payable in accordance with the schedule set forth herein. In the event of your death prior to payment in full of the Severance Payments, the Company
                  shall pay your estate the remaining unpaid Severance Payments.</font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 4 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zf1cb84d9b3784787a57fd0090279046d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">c.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination Following a Change in Control</u></font><font style="font-size: 10pt;">.&#160; If, at any
                  time during the 90 day period preceding, or 24 month period following, a Change in Control, your employment with the Company is terminated without Cause or you resign for Good Reason, in addition to the Accrued Benefits, the Company will
                  pay or provide you with the following: (i)(A) an aggregate dollar amount equal to the product of (x) 3.0 multiplied by (y) the sum of (I) your Annual Base Salary in effect immediately prior to your termination of employment or the
                  occurrence of Good Reason (whichever is higher) plus (II) the Target Bonus, payable as follows: (1) if the Change in Control is also a &#8220;change in control event&#8221; for purposes of Code Section 409A, the amount in this clause (i)(A) will be
                  paid in a single lump sum within the 60-day period following the date your employment ends (or if later, the date of such Change in Control) or (2) if the Change in Control does not constitute a &#8220;change in control event&#8221; for purposes of
                  Code Section 409A, the amount in this clause (i)(A) will be paid in equal installments over the 24 month period immediately following the date of termination of employment; (B) COBRA Continuation; (C) the Pro-Rata Bonus (collectively, &#8220;<font style="font-family: 'Times New Roman';"><u>CIC Severance Payments</u></font>&#8221;) and (ii)(A) with respect to any unvested equity-based incentive awards subject to time-based vesting, you will immediately become fully vested in, and all
                  options shall immediately become exercisable or cash or shares will be immediately settled or distributed with respect to, all such awards, and (B) with respect to any unvested equity-based incentive awards subject to performance-based
                  vesting, you will vest in, and options shall become exercisable, or cash or shares will be settled or distributed, assuming performance at target levels applicable to all such awards had been achieved (regardless of actual performance)
                  (collectively, &#8220;<font style="font-family: 'Times New Roman';"><u>CIC Equity Vesting</u></font>&#8221;). The Company&#8217;s obligation to make CIC Severance Payments or provide the CIC Equity Vesting is conditioned upon your execution and delivery of
                  the Release. To the extent any equity grant agreement or other agreement between the Company and you contains provisions accelerating the vesting of unvested equity awards upon a Change in Control (or similar term) or termination of your
                  employment without Cause or a resignation for Good Reason that are more favorable to you than the CIC Equity Vesting, then the vesting provisions of such equity grant or other agreement will govern. The Company will commence payment (or
                  reimbursement, to the extent required by Code Section 409A) of the Severance Payments 60 days following the date of termination of your employment, <font style="font-family: 'Times New Roman';"><u>provided</u></font> that prior to such
                  date, the Release has become effective in accordance with its terms. The first payment will include a catch-up payment covering the amount that would have otherwise been paid during the period between the date of your termination of
                  employment and the first payment date but for the application of the preceding sentence, and the balance of the installments will be payable in accordance with the schedule set forth herein. In the event of your death prior to payment in
                  full of the CIC Severance Payments, the Company shall pay your estate the remaining unpaid CIC Severance Payments. In no event shall you be obligated to seek other employment or take any other action by way of mitigation of the amounts
                  payable to you under any of the provisions of this Agreement, nor shall the amount of any payment hereunder be reduced by any compensation earned by you as a result of employment by a subsequent employer, except to the limited extent
                  provided with respect to COBRA Continuation.</font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 5 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">14.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>No Excise Tax Gross-Up; Possible Reduction in Parachute Payments</u></font>.&#160; Notwithstanding any restrictions set forth in any Company plan or arrangement, if any portion of your Severance
            Payments, CIC Severance Payments, Equity Vesting, CIC Equity Vesting or any other payments in the nature of compensation provided to you (each, a &#8220;<font style="font-family: 'Times New Roman';"><u>Payment</u></font>&#8221;) constitutes &#8220;parachute
            payments&#8221; within the meaning of Section 280G of the Code and, but for this subsection, would be subject to the excise tax imposed by Section 4999 of the Code (the &#8220;<font style="font-family: 'Times New Roman';"><u>Excise Tax</u></font>&#8221;), then
            your Payments will be payable either in full or in such lesser amount as would result, after taking into account the applicable federal, state and local income taxes and the Excise Tax, in your receipt on an after-tax basis of the greater
            amount of Payments. Any reduction in the Payments pursuant to the preceding sentence shall be effected first by reducing or eliminating Severance Payments or CIC Severance Payments, as applicable, and then by reducing or eliminating the Equity
            Vesting or CIC Equity Vesting, and then by reducing other compensation and benefits. Such reductions shall be allocated pro rata between amounts that are subject to Section 409A of the Code and amounts that are not subject to Section 409A of
            the Code. Any determination required under this section shall be made in writing by the Company&#8217;s independent public accountants (the &#8220;<font style="font-family: 'Times New Roman';"><u>Accountants</u></font>&#8221;), whose determination shall be
            conclusive and binding upon you and the Company for all purposes. For purposes of making the calculations required by this section, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on
            reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and you shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to
            make a determination under this section. The Company shall bear all costs and fees of the Accountants in connection with any calculations contemplated by this section. No less than five days prior to a change in ownership, the Company shall
            provide you, or permit the Accountants to provide you, with all calculations and supporting documentation related to the determination of the Excise Tax. The Company&#8217;s obligations under this section shall survive your termination of employment.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">15.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Indemnification</u></font>.&#160; If you are made or threatened to be made a party to or a participant in any actual, threatened, pending, or completed action, claim, or proceeding of any type,
            the Company shall indemnify, defend, and hold you harmless to the fullest extent authorized or permitted by applicable law, by its Certificate of Incorporation, and by its By-Laws, as the foregoing may be amended from time to time, and
            including any and all expenses (including, without limitation, advancement and payment of attorneys&#8217; fees) and losses arising out of or relating to any of your actual or alleged acts, omissions, negligence or active or passive wrongdoing,
            including the advancement of expenses you incur. In addition, without limiting the foregoing, the Company shall provide you with indemnification protection under any separate written indemnification agreement entered into with executives and
            directors of the Company on terms no less favorable than provided to any other Company executive officer or director. Further, in the event you prevail on any material issue in connection with any controversy, dispute or claim which arises out
            of or relates to this Agreement, any other agreement or arrangement between you and the Company, your employment with the Company, or the termination thereof, then the Company shall reimburse you (and your beneficiaries) for any and all costs
            and expenses (including without limitation attorneys&#8217; fees) incurred by you (or any of your beneficiaries) in connection with such controversy, dispute or claim. In addition, during your employment with the Company and while potential liability
            exists (but in no event less than six years thereafter), the Company or any successor to the Company shall purchase and maintain, at its own expense, directors&#8217; and officers&#8217; liability insurance providing coverage to you on terms that are no
            less favorable than the coverage provided to other directors and officers of Company.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 6 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">16.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Confidential Information; Work Product</u></font>.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zc2393d851cd1435a9852052bd88f4d67" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Definition of Confidential Information</u></font><font style="font-size: 10pt;">.&#160; As used in this
                  Agreement, &#8220;<font style="font-family: 'Times New Roman';"><u>Confidential Information</u></font>&#8221; includes, but is not limited to, any type of trade secret or other information, whether in hard-copy or electronic format or communicated
                  orally, relating to the business of the Company that you acquire or have acquired through employment with the Company, and that has value such that the Company designates or treats the information as confidential through its policies,
                  procedures and/or practices. Confidential Information is limited to information that is not generally known to competitors or that is not in the public domain through lawful means. Confidential Information does not include information
                  that has been voluntarily disclosed to the public by the Company (except where such public disclosure has been made in breach of a duty of confidentiality); information known to you prior to first receipt of or access to such information
                  in the course of your employment with the Company; or information that has been independently developed and disclosed by, or rightfully received by you outside the course of your employment with the Company from, a third party who does
                  not owe the Company, as applicable, a duty of confidentiality with respect to such information. Subject to the foregoing, examples of Confidential Information include, without limitation, the following: (i) any files, lists or other
                  information relating to customers; (ii) non-published pricing and financial information and data; (iii) strategic, marketing and research information including, without limitation, business plans, strategies and market research data; (iv)
                  technical information including, without limitation, software, source code, object code and other non-public intellectual property; and (v) product research and development including, without limitation, testing data, formulas, products
                  in development and all other research data.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zdcfd343f492b4c6eb5a265a980c344fa" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Non-Disclosure of Confidential Information</u></font><font style="font-size: 10pt;">.&#160; You
                  acknowledge that the Company has spent considerable time, effort and expense developing its Confidential Information and has taken reasonable measures to protect its secrecy. You therefore acknowledge and agree that you will not, except
                  in the normal course of your duties on behalf of the Company, disclose or use, or enable anyone else to disclose or use, either during your employment with the Company or at any time subsequent thereto, any Confidential Information
                  without prior written approval from the Company.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zc0650f993a044737897ac8052f892339" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">c.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Return of Company Property</u></font><font style="font-size: 10pt;">.&#160; You agree that all
                  documents and other materials of any kind pertaining to the business of the Company (including Confidential Information in any format) in your possession at any time during your employment are and shall be the property of the Company and
                  that all such property, including all copies thereof and all such information contained on your personal computer(s), your personal smart phone, your other personal devices, or any other storage devices (electronic or otherwise) shall be
                  surrendered by you to the Company upon the Company&#8217;s request from time to time during your employment, and with or without request upon, or within a reasonable period following, the termination of your employment.</font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 7 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">17.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Ownership of Property</u></font>.&#160; You acknowledge that all discoveries, concepts, ideas, inventions, innovations, improvements, developments, methods, processes, programs, designs,
            analyses, drawings, reports, patent applications, copyrightable work and mask work (whether or not including any confidential information) and all registrations or applications related thereto, all other proprietary information and all similar
            or related information (whether or not patentable) that relate to the Company&#8217;s actual or anticipated business, research and development, or existing or future products or services and that are conceived, developed, contributed to, made or
            reduced to practice by you (either solely or jointly with others) while employed by the Company (including any of the foregoing that constitutes any proprietary information or records) (&#8220;<font style="font-family: 'Times New Roman';"><u>Work
                Product</u></font>&#8221;) belong to the Company and you hereby assign, and agree to assign, all of the above Work Product to the Company. Any copyrightable work prepared in whole or in part by you in the course of your work for any of the
            foregoing entities shall be deemed a &#8220;work made for hire&#8221; under the copyright laws and the Company shall own all rights therein. To the extent that any such copyrightable work is not a &#8220;work made for hire,&#8221; you hereby assign and agree to assign
            to the Company all right, title, and interest, including without limitation, copyright in and to such copyrightable work. You understand, however, that there is no obligation being imposed on you to assign any invention falling within the
            definition of Work Product for which no equipment, supplies, facility, or trade secret information of the Company was used and that was developed entirely on your own time, unless (i) such Work Product relates (a) to the Company&#8217;s businesses or
            (b) to the Company&#8217;s actual or demonstrably anticipated research or development, or (ii) the Work Product results from any work performed by you under this Agreement.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">18.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Non-Disparagement</u></font>.&#160; You agree that you will not at any time make, publish or communicate to any person or entity or in any public forum any defamatory or disparaging remarks,
            comments, or statements concerning the Company, other than in the performance of your duties for the Company. The Company and its respective officers and directors, respectively, agree that it and they will not at any time make, publish or
            communicate to any person or entity or in any public forum any defamatory or disparaging remarks, comments, or statements concerning you. The foregoing shall not be violated by truthful statements in response to legal process, required
            governmental testimony or filings, or administrative or arbitral proceedings (including, without limitation, depositions in connection with such proceedings).</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">19.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Non-Competition</u></font>.&#160; You covenant and agree that at all times during your employment by the Company and for a period of 24 months following termination of your employment for any
            reason or no reason, you shall not, directly or indirectly, individually or jointly, own any interest in, operate, or participate as a partner, advisor, board member, director, principal, officer or agent of, enter into the employment of, act
            as a consultant to, or perform any services for any person or entity (other than the Company), that engages in the Business in the Restricted Area (as those terms are defined herein). Notwithstanding anything herein to the contrary, this
            section shall not prevent you from owning not more than five percent (5%) in the aggregate of any class of equity of any company if such equity is publicly traded and listed on any national or regional stock exchange. In addition, the
            provisions of this section shall not be violated by you commencing employment with a subsidiary, division or unit of any entity that engages in the Business so long as you and such subsidiary, division or unit do not engage in the Business.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 8 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">20.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Non-Solicitation</u></font>.&#160; During your employment by the Company and for a period of 24 months following termination of your employment for any reason or no reason: (a) you, except as
            part of your duties to the Company, shall not directly or indirectly, for your own benefit or on behalf of any other person or entity, for the purpose of entering into a Restricted Transaction, solicit, call on, service or enter into any
            agreement with any customer with whom the Company did any business within the 12 month period preceding the termination of your employment with the Company, and with whom you had contact for the purpose of a Restricted Transaction, for whom you
            had supervisory responsibility or about whom you had access to and used Confidential Information; (b) you shall not, directly or indirectly, for your own benefit or on behalf of any other person or entity, solicit, induce or encourage any
            employee of the Company with whom you had material contact to leave such employee&#8217;s employment with the Company or to cease such employee&#8217;s relationship with the Company; and (c) you shall not, directly or indirectly, for your own benefit or on
            behalf of any other person or entity encourage (or assist another in encouraging) any supplier, business partner, or vendor of the Company with whom you had any contact on behalf of the Company within the last 12 months of your employment with
            the Company to terminate or diminish its relationship with the Company. For purposes of this section, &#8220;<font style="font-family: 'Times New Roman';"><u>Restricted Transaction</u></font>&#8221; means the marketing, selling and/or providing of products
            or services of the type marketed, sold, actively developed or provided by the Company during the 12 month period prior to the termination of your employment. Notwithstanding the foregoing, the provisions of this section shall not be violated by
            (a) general advertising or solicitation not specifically targeted at Company-related persons or entities, (b) you serving as a reference, upon request, for any employee of the Company, or (c) actions taken by any person or entity with which you
            are associated if you are not personally involved in any manner in the matter and have not identified such Company-related person or entity for soliciting or hiring.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">21.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Enforcement</u></font>.&#160; You agree and acknowledge that the Restrictive Covenant Provisions do not preclude you from earning a livelihood, nor do they unreasonably impose limitations on your
            ability to earn a living. You acknowledge that you have carefully read this Agreement and have given careful consideration to the restraints imposed on you by this Agreement, and you are in full accord as to their necessity for the reasonable
            and proper protection of confidential and proprietary information of the Company now existing or to be developed in the future. You expressly acknowledge and agree that each and every restraint imposed by this agreement is reasonable with
            respect to subject matter, time period and geographical area. In the event you breach any provision hereof, the Company shall be entitled to entry of an injunction prohibiting the same, in addition to any other remedy or relief that may be
            available to the Company at law or in equity. If you breach any provision herein, the time periods relating to the restrictions in the Restrictive Covenant Provisions shall be extended for a period of time equal to that period of time during
            which you are determined to be in breach.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 9 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">22.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Definitions</u></font>.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z11bf6e022d5d41d2840cda083c7fb8bd" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Business</u></font>&#8221; means the business of (i) developing, acquiring, managing, producing, marketing, providing and selling
                titanium ore and titanium dioxide and (ii) mining and beneficiating mineral sands.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z1c3cf27db48346d3a6aa98cf12e07e80" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Cause</u></font>&#8221; means (i) the arrest, indictment, conviction or plea of guilty or no contest for any felony or any
                misdemeanor involving acts of dishonesty or moral turpitude which in the estimation of the Board, acting reasonably, would disqualify you from serving as an executive officer of the Company; (ii) the willful commission of an act involving
                misappropriation, embezzlement or fraud which involves a material matter with respect to the Company or any of its customers or suppliers; (iii) substantial and repeated failure to perform duties of the office you hold as reasonably
                directed by the Board; (iv) gross negligence or willful misconduct with respect to the Company that is or could reasonably be expected to be harmful to the Company in any material respect; (v) willful conduct bringing the Company into
                substantial public disgrace or disrepute, and (vi) any material breach by you of this Agreement or any of the Company&#8217;s material policies. Any determination of Cause by the Company will be made by a resolution approved by a two-thirds
                majority of the members of the Board, <font style="font-family: 'Times New Roman';"><u>provided</u></font> that no such determination of Cause may be made until you have been given written notice detailing the specific Cause event (which
                such notice must be provided to you within 30 days of the occurrence of the alleged event constituting Cause), and you have been given a period of at least 30 days following receipt of such notice to cure such event (if susceptible to
                cure). To the extent an event is not so cured or deemed not susceptible to cure, the Board shall provide you with an opportunity on at least ten days advance written notice to appear (with legal counsel) before the full Board to discuss the
                specific circumstances alleged to constitute a Cause event. For purposes of this definition, an act, or a failure to act, shall not be deemed willful or intentional, as those terms are defined herein, unless it is done, or omitted to be
                done, by you in bad faith or without a reasonable belief that your action or omission was in the best interest of the Company.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zc6ebd8b869ee438292e1301dfd2709f9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">c.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Change in Control</u></font>&#8221; means a &#8220;Change of Control&#8221; as that term is defined in the Tronox Holdings plc Management Equity
                Incentive Plan, as amended, as in effect on the date hereof.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z6b3b3aabe4334f2791caa4fee717558d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">d.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Code</u></font>&#8221; means the Internal Revenue Code of 1986, as amended.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 10 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z7f1e3169b2044d1897271e64b56c15cc" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">e.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Good Reason</u></font>&#8221; means (i) a reduction in your Annual Base Salary, (ii) a diminution in your title or a diminution in
                your duties or responsibilities inconsistent with your position including without limitation being asked to resign as a member from the Company&#8217;s Board of Directors (but, excluding an individual event resulting in a de minimis diminution in
                your duties or responsibilities), provided, however, that if you provide notice of resignation after such a diminution in your title, duties or responsibilities, you agree to provide the Company with continued service in a professional and
                capable manner for a period of up to six months after such notice (although such period may be reduced in the discretion of the Company), (iii) a material breach of this Agreement by the Company or a material breach by the Company of
                another material agreement between you and the Company, or (iv) the failure of the Company to obtain the assumption (by operation of law, the continuation of the corporate existence of the Company or otherwise) of this Agreement or
                substitution of a substantially similar agreement by any successors in a Change of Control, in each case without your prior written consent; <font style="font-family: 'Times New Roman';"><u>provided</u></font> that you must deliver written
                notice of your resignation to the Company within 90 days of your actual knowledge of any such event, the Company must be provided at least 30 days during which it may remedy the condition and you must terminate your employment within six
                months of the initial occurrence of Good Reason in order for such resignation to be with Good Reason for any purpose hereunder (except as set forth in (ii) above).</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="ze5a5ef8473cf4ab5abf3844417b751be" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">f.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Person</u></font>&#8221; means an individual, a partnership, a limited liability company, a corporation, an association, a joint
                stock company, a trust, a joint venture, an unincorporated organization, investment fund, any other business entity and a governmental entity or any department, agency or political subdivision thereof.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z5b4eaf970bc14fa3b9563f7e32257c3d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">g.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Release</u></font>&#8221; means an agreement executed by you in a form mutually agreeable between you and the Company that contains:
                (i) an acknowledgement by the Company that it does not know (upon reasonable diligence) of any claims against you and (ii) a general release and waiver by you of any and all claims against the Company; <font style="font-family: 'Times New Roman';"><u>provided</u></font> that the Release shall specifically exclude: (a) any right to the benefits, including, without limitation, any severance benefits, to which you are entitled under this Agreement, (b) any claim relating to
                directors&#8217; and officers&#8217; liability insurance coverage or any right of indemnification under the Company&#8217;s or its affiliates&#8217; organizational documents, applicable law or otherwise, (c) any rights you may have as a member or holder of equity
                or other securities of the Company or its affiliates, and (d) any rights or entitlements under any applicable sale or transaction agreement. For the sake of clarity, the Company may require that you re-affirm in the Release the Restrictive
                Covenants set forth herein, but the Company may not impose additional restrictive covenants on you.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zc40b3117e3b14306b379676cba6dd335" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">h.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Restricted Area</u></font>&#8221; means each country throughout the world in which the Company conducts the Business.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 11 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z84879578a9ba47b2857c6a8dabbb4666" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">i.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Restrictive Covenants</u></font>&#8221; means, collectively, the sections of this Agreement captioned &#8220;Confidential Information;
                Work Product;&#8221; &#8220;Ownership of Property;&#8221; &#8220;Non-Disparagement;&#8221; &#8220;Non-Competition;&#8221; and &#8220;Non-Solicitation.&#8221;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z060758447657439ea16c53eaf769e477" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">j.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman';"><u>Subsidiary</u></font>&#8221; means, with respect to any Person, any corporation, limited liability company, partnership,
                association, or business entity of which (i) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers, or
                trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (ii) if a limited liability company, partnership, association,
                or other business entity (other than a corporation), a majority of partnership or other similar ownership interest thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person
                or a combination thereof. For purposes hereof, a Person or Persons shall be deemed to have a majority ownership interest in a limited liability company, partnership, association, or other business entity (other than a corporation) if such
                Person or Persons shall be allocated a majority of limited liability company, partnership, association, or other business entity gains or losses or shall be or control any managing director or general partner of such limited liability
                company, partnership, association, or other business entity.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">23.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Compensation Recovery (Clawback)</u></font>.&#160; Any amounts of compensation paid or awarded to you under this Agreement shall be subject to compensation recovery (clawback) to the extent
            required by applicable law or regulations in the event the Company is required to prepare an accounting restatement due to the material noncompliance of the Company with any financial reporting requirements under the securities laws and the
            amounts received based on erroneous data was in excess of what would have been received by you had such noncompliance not occurred.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">24.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Representations</u></font>.&#160; You hereby represent to the Company that (a) you have the legal right to enter into this Agreement and to perform all of the obligations on your part to be
            performed hereunder in accordance with its terms, and (b) you are not a party to any agreement or understanding, written or oral, and are not subject to any restriction, which, in either case, could prevent you from entering into this Agreement
            or performing your duties and obligations hereunder.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 12 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">25.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Arbitration</u></font>.&#160; The parties agree that any controversy or claim arising out of or relating to this Agreement, or the alleged breach thereof, shall be submitted for resolution to the
            American Arbitration Association (&#8220;<font style="font-family: 'Times New Roman';"><u>AAA</u></font>&#8221;) and that three (3) neutral arbitrators will be selected to adjudicate such controversy or claim in a manner consistent with the AAA Employment
            Arbitration Rules then in effect (the &#8220;<font style="font-family: 'Times New Roman';"><u>Rules</u></font>&#8221;). The arbitration proceedings will allow for discovery according to the Rules.&#160; All arbitration proceedings shall be conducted in
            Stamford, Connecticut. The parties are entitled to representation by an attorney or other representative of their choosing. The Company shall bear the costs of the arbitration filing and hearing fees and the cost of the arbitrators. Such
            arbitration shall be the sole, exclusive and final remedy for any dispute between you and the Company relating to this Agreement, the employment relationship between you and the Company and any disputes upon termination of employment, other
            than claims for workers&#8217; compensation, unemployment insurance benefits, or alleged or threatened breaches of any of the Restrictive Covenants. <font style="font-family: 'Times New Roman'; font-weight: bold;">Accordingly, you and the Company
              each acknowledges and agrees that each is waiving all respective rights to file an action in court or to receive a trial by jury with respect to any and all claims that are subject to arbitration as set forth herein.</font> Either party may
            exercise the right to arbitrate by providing the other party with written notice of any and all claims forming the basis of such right in sufficient detail to inform the other party of the substance of such claims. Notwithstanding the
            foregoing, in the event you breach or threaten to breach any of the Restrictive Covenants, the Company shall be entitled to entry of an injunction prohibiting same, in addition to any other remedy or relief that may be available to Company at
            law or in equity. In the event of a breach or threatened breach of any such Restrictive Covenant, you agree that, in addition to any other remedies available at law or equity, the Company may file litigation against you seeking specific
            performance and temporary and/or preliminary injunctive relief, enjoining or restraining such breach or threatened breach, and you consent to the issuance of such injunctive relief without bond. You also agree that any action seeking such
            injunctive or equitable relief may be filed in any state or federal court located within Connecticut and that you shall be subject to personal jurisdiction in any such court.&#160; Notwithstanding anything set forth herein, the parties&#8217; arbitration
            agreement set forth in this section shall expire immediately following a Change in Control.&#160; Following the arbitration expiration date, the parties agree that any controversy or claim arising out of or relating to this Agreement, or breach
            thereof, shall be submitted for resolution only to the state or federal courts located within Connecticut.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">26.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Code Section 409A</u></font>.&#160; This Agreement is intended to comply with Section 409A or an exemption thereunder and shall be construed and administered in accordance with Section 409A.
            Notwithstanding any other provision of this Agreement, payments provided under this Agreement may only be made in a manner that complies with Section 409A or an applicable exemption. Any payments under this Agreement that may be excluded from
            Section 409A either as separation pay due to an involuntary separation from service or as a short-term deferral shall be excluded from Section 409A to the maximum extent possible. For purposes of Section 409A, each installment payment provided
            under this Agreement shall be treated as a separate payment. Any payments to be made under this Agreement upon a termination of employment that are considered &#8220;nonqualified deferred compensation&#8221; for purposes of Section 409A shall only be made
            upon a &#8220;separation from service&#8221; under Section 409A. Notwithstanding any other provision of this Agreement, if any payment or benefit provided to you in connection with your termination of employment is determined to constitute &#8220;nonqualified
            deferred compensation&#8221; within the meaning of Section 409A and you are determined to be a &#8220;specified employee&#8221; as defined in Section 409A(a)(2)(b)(i), then such payment or benefit shall not be paid until the first payroll date to occur following
            the six-month anniversary of the date of your termination of employment or, if earlier, on your death (the &#8220;<font style="font-family: 'Times New Roman';"><u>Specified Employee Payment Date</u></font>&#8221;). The aggregate of any payments that would
            otherwise have been paid before the Specified Employee Payment Date and interest on such amounts calculated based on the applicable federal rate published by the Internal Revenue Service for the month of your termination of employment shall be
            paid to you in a lump sum on the Specified Employee Payment Date and thereafter, any remaining payments shall be paid without delay in accordance with their original schedule. To the extent required by Section 409A, each reimbursement or
            in-kind benefit provided under this Agreement shall be provided in accordance with the following (a) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during each calendar year cannot affect the expenses eligible
            for reimbursement, or in-kind benefits to be provided, in any other calendar year; (b) any reimbursement of an eligible expense shall be paid to you on or before the last day of the calendar year following the calendar year in which the expense
            was incurred; and (c) any right to reimbursements or in-kind benefits under this Agreement shall not be subject to liquidation or exchange for another benefit.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 13 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">27.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Severability</u></font>.&#160; In the event that any part or provision of this Agreement shall be held to be invalid or unenforceable by any arbitrator or court of competent jurisdiction, the
            remaining provisions thereof shall nevertheless continue to be valid and enforceable as though the invalid or unenforceable part or provision had not been included therein. Further, in the event that any part or provision hereof shall be
            declared by a court of competent jurisdiction to exceed the maximum time period, scope or activity restriction that such court deems reasonable and enforceable, then the parties expressly authorize the court to modify such part or provision so
            that it may be enforced to the maximum extent permitted by law.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">28.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>No Waiver</u></font>.&#160; The failure by either party at any time to require performance or compliance by the other of any of its obligations or agreements shall in no way affect the right to
            require such performance or compliance at any time thereafter. The waiver by either party of a breach of any provision hereof shall not be taken or held to be a waiver of any preceding or succeeding breach of such provision or as a waiver of
            the provision itself. No waiver of any kind shall be effective or binding, unless it is in writing and is signed by the party against whom such waiver is sought to be enforced.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">29.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Assignment</u></font>.&#160; This Agreement and all rights hereunder are personal to you and may not be transferred or assigned by you at any time. The Company may assign its rights, together
            with its obligations hereunder, to any parent, subsidiary or successor, or in connection with any sale, transfer or other disposition of all or substantially all of its business and assets provided, however, that any such assignee assumes the
            Company&#8217;s obligations hereunder.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">30.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Tax Withholding and Equalization</u></font>.&#160; All sums payable to you hereunder shall be reduced by all federal, state, local and other withholding and similar taxes and payments required by
            applicable law.&#160; The Company will tax equalize you for any personal income taxes in the United Kingdom that become due and payable from you in connection with business conducted in the United Kingdom due to your executive and/or Board
            activities on behalf of the Company.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">31.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Entire Agreement</u></font>.&#160; This Agreement constitutes the entire and only agreement and understanding between the parties relating to your employment with the Company. This Agreement
            supersedes any and all previous contracts, arrangements or understandings with respect to your employment with the Company, including the Prior Employment Agreement.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 14 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">32.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Amendment</u></font>.&#160; The parties understand and agree that this Agreement may not be amended, modified or waived, in whole or in part, except in a writing executed by you and the Chair of
            the Board or the Lead Director as the case may be.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">33.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Notices</u></font>.&#160; All notices, if any, and all other communications, if any, required or permitted under this Agreement shall be in writing and hand delivered, sent via facsimile, sent by
            registered first class mail, postage pre-paid, or sent by nationally recognized express courier service. Such notices and other communications shall be effective upon receipt if hand delivered or sent via facsimile, five (5) days after mailing
            if sent by mail, and one (1) day after dispatch if sent by express courier, to the following addresses, or such other addresses as any party shall notify the other parties:</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; margin-left: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If to the Company:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; margin-left: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tronox Holdings plc</div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">One Stamford Plaza</div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">263 Tresser Boulevard, Suite 1100</div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Stamford, Connecticut 06901</div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Attention: General Counsel</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If to you:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Jean Fran&#231;ois Turgeon</div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Contact information on file.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">34.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Counterparts</u></font>.&#160; This Agreement may be executed in multiple counterparts and delivered by facsimile or electronic (.pdf or .tiff) signature, each of which shall be considered an
            original and all of which, when taken together, shall be considered a single agreement.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 15 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">35.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Governing Law</u></font>.&#160; This Agreement and the rights and obligations of the parties hereto shall be construed in accordance with the laws of the State of Connecticut, without giving
            effect to the principles of conflict of laws.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Company and you have executed this Agreement as of the date set forth below.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">ACCEPTED and AGREED to by</font><font style="font-size: 10pt;">:</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" id="zb9f5606f38b74322a3bf1287821ca6c9" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="vertical-align: top;" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">TRONOX HOLDINGS PLC</div>
              </td>
              <td style="vertical-align: top;" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">EXECUTIVE</div>
              </td>
            </tr>
            <tr>
              <td style="vertical-align: top; font-size: 10pt;" colspan="2">&#160;</td>
              <td style="vertical-align: top; font-size: 10pt;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top;" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">By:&#160; <u><font style="font-family: 'Times New Roman';">/s/ Ilan Kaufthal</font></u></div>
              </td>
              <td style="vertical-align: top;" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">By:&#160; <font style="font-family: 'Times New Roman';"><u>/s/ </u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Jean Fran&#231;ois
                      Turgeon</u></font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><br>
                </div>
              </td>
              <td style="width: 47%; vertical-align: top;">Ilan Kaufthal</td>
              <td style="width: 3%; vertical-align: top;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br>
                </div>
              </td>
              <td style="width: 47%; vertical-align: top;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Jean Fran&#231;ois Turgeon</div>
              </td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><br>
                </div>
              </td>
              <td style="width: 47%; vertical-align: top;">Chair of the Board</td>
              <td style="vertical-align: top; font-size: 10pt;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top; font-size: 10pt;" colspan="2">&#160;</td>
              <td style="vertical-align: top; font-size: 10pt;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top;" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Date: March 18, 2021</div>
              </td>
              <td style="vertical-align: top;" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Date: March 18, 2021</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">- 16 - </font></div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>brhc10021910_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%2%% | Page%-->
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
  </div>
  <div> <br>
  </div>
  <div>
    <div style="text-align: left;"><img src="image00001.jpg"></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">March 18, 2021</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Tronox Appoints John D. Romano and Jean-Fran&#231;ois Turgeon co-Chief Executive Officers</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Ilan Kaufthal Elected Chairman of the Board</div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">STAMFORD, Conn., March 18, 2021 &#8211; <a name="z_Hlk66890989"></a>Tronox Holdings plc (NYSE:TROX) (&#8220;Tronox&#8221; or the &#8220;Company&#8221;), a leading integrated manufacturer of titanium
      dioxide pigment, <a name="z_Hlk40098036"></a>today announced that its Board of Directors (the "Board") appointed John D. Romano and Jean-Fran&#231;ois Turgeon as co-Chief Executive Officers (&#8220;co-CEOs&#8221;) and as members of the Board of the Company,
      effective immediately.&#160; In addition, Ilan Kaufthal has been elected Chairman of the Board, effective immediately.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company also announced the retirement of former Chairman and Chief Executive Officer Jeffry N. Quinn, effective immediately, following his previously announced leave of
      absence from the Company.&#160; Mr. Kaufthal, Mr. Romano and Mr. Turgeon have been serving in their respective roles on an interim basis since December 27, 2020.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;John and Jean-Fran&#231;ois have extensive combined leadership and operational experience in the pigment and mining industries, including many years at Tronox. <a name="z_Hlk66891004"></a>Their demonstrated ability to lead as co-CEOs over the last two and a half months reinforces the Board&#8217;s confidence in their ability to continue to successfully execute on the Company&#8217;s long-term strategic plan,&#8221; <a name="z_Hlk59017564"></a>stated Mr. Kaufthal. &#8220;They<a name="z_Hlk59087798"></a> possess the right mix of skills and leadership capabilities that led the Board to determine that the co-CEO structure, with John and Jean-Fran&#231;ois at the helm, is the
      best path forward for the Company and its stakeholders.&#8221;</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Hlk23758099"></a><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>About Tronox</u></font></div>
    <div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Tronox Holdings plc is one of the world's leading producers of high-quality titanium products, including
          titanium dioxide pigment, specialty-grade titanium dioxide products and high-purity titanium chemicals; and zircon. We mine titanium-bearing mineral sands and operate upgrading facilities that produce high-grade titanium feedstock materials, pig
          iron and other minerals. With nearly 6,500 employees across six continents, our rich diversity, unmatched vertical integration model, and unparalleled operational and technical expertise across the value chain, position </font>Tronox<font style="font-size: 10pt; font-family: 'Times New Roman';"> as the preeminent titanium dioxide producer in the world. For more information about how our products add brightness and durability to paints, plastics, paper and other everyday products,
          visit </font><u><font style="font-family: 'Times New Roman'; font-size: 10pt;">Tronox.com</font></u><font style="font-size: 10pt; font-family: 'Times New Roman';">.</font></div>
      <div><br>
      </div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>Forward Looking Statements</u></div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Statements in this release that are not historical are forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These
      forward-looking statements, which are subject to known and unknown risks, uncertainties and assumptions about us, may include projections of our future financial performance including the effects of the COVID-19 pandemic and anticipated synergies
      based on our growth and other strategies, anticipated completion of extensions and upgrades to our mining and operations, and anticipated trends in our business. These statements are only predictions based on our current expectations and projections
      about future events. There are important factors that could cause our actual results, level of activity, performance, actual synergies, or achievements to differ materially from the results, level of activity, performance, anticipated synergies or
      achievements expressed or implied by the forward-looking statements. Significant risks and uncertainties may relate to, but are not limited to, business and market disruptions related to the COVID-19 pandemic, market conditions and price volatility
      for titanium dioxide, zircon and other feedstock materials, as well as global and regional economic downturns, including as a result of the COVID-19 pandemic, that adversely affect the demand for our end-use products; disruptions in production at our
      mining and manufacturing facilities; and other financial, economic, competitive, environmental, political, legal and regulatory factors. These and other risk factors are discussed in the Company's filings with the Securities and Exchange Commission.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for our management
      to predict all risks and uncertainties, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any
      forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, synergies or achievements. Neither we nor any other
      person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Unless otherwise required by applicable laws, we undertake
      no obligation to update or revise any forward-looking statements, whether because of new information or future developments.</div>
    <div><br>
    </div>
    <div>
      <div style="text-align: left; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Media Contact: Melissa Zona</div>
      <div style="text-align: left; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">+1.636.751.4057</div>
    </div>
    <div>&#160;</div>
    <div style="text-align: left; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Investor Contact: Jennifer Guenther</div>
    <div style="text-align: left; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;+1.646.960.6598</div>
    <div style="text-align: left; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div></div>
  </div>
  <br>
  <div id="DSPFPageFooter" style="width: 100%;"> </div>
  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>trox-20210318.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://tronox.com/20210318" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:trox="http://tronox.com/20210318" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="trox-20210318_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="trox-20210318_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://tronox.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>trox-20210318_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>trox-20210318_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://tronox.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="trox-20210318.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tronox.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  X .<# 2(  A$! Q$!_\0
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M<1!]H(?.,],X'Y"O4?&OPW\(-X7U4QZ#IUO+':2RI+%$$9&5201CK@XKYO\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>brhc10021910_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="trox-20210318.xsd" xlink:type="simple"/>
    <context id="c20210318to20210318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001530804</identifier>
        </entity>
        <period>
            <startDate>2021-03-18</startDate>
            <endDate>2021-03-18</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20210318to20210318"
      id="Fact_a7c5d9e596674a0bbeceba9cfe2cc7db">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName
      contextRef="c20210318to20210318"
      id="Fact_59ac52a45a6642d3a746fc04cc81114a">Tronox Holdings plc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20210318to20210318"
      id="Fact_8cca3f4e583a41edb115f36e868cb375">X0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityCentralIndexKey
      contextRef="c20210318to20210318"
      id="Fact_49dae5e41193474ab699073fc646adef">0001530804</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20210318to20210318"
      id="Fact_a01eb2db74364d6ba3687cac0654a9c9">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20210318to20210318"
      id="Fact_9ff6b029ea98487b8c18e002e91d9317">2021-03-18</dei:DocumentPeriodEndDate>
    <dei:EntityFileNumber
      contextRef="c20210318to20210318"
      id="Fact_b5f5bd7261e343fe89be96653fad3861">001-35573</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20210318to20210318"
      id="Fact_7e4ba92d73d341e5a9d4cc17ffa464da">98-1467236</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20210318to20210318"
      id="Fact_7021556e67f7443180beea2f02229f3b">263 Tresser Blvd., Suite 1100</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20210318to20210318"
      id="Fact_6844bdfef2ec482d8e788ab1d18a000b">Stamford</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20210318to20210318"
      id="Fact_ab672749c7e7497592617e19bcd43a0e">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20210318to20210318"
      id="Fact_55ab067ecb804b6199df6dbbdca09369">06901</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20210318to20210318"
      id="Fact_b546b7da9e4f4781af3a7d48f8e09033">203</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20210318to20210318"
      id="Fact_e020b9059b004fee8e86afd97df11b41">705-3800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20210318to20210318"
      id="Fact_e6cba4bb88ae4c949bfd1e2243953618">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20210318to20210318"
      id="Fact_5cb80e84a1274c3fade1f7a8d0f32641">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20210318to20210318"
      id="Fact_99a630e628234393934dd7b075bd8b92">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20210318to20210318"
      id="Fact_8627eae0a96440b7999059d5c9e1e0ea">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20210318to20210318"
      id="Fact_4b873e43b1284f76b718ff313f54165e">Ordinary shares, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20210318to20210318"
      id="Fact_7916656328654921bb6239f8afba8b65">TROX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20210318to20210318"
      id="Fact_982751ad610e4121901153c56a9cbed6">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20210318to20210318"
      id="Fact_3bbf92582e6c4d98930ee95636041436">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139862464133880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 18, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 18,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Tronox Holdings plc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">X0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1467236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">263 Tresser Blvd., Suite 1100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Stamford<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">705-3800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001530804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TROX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( /M"<E('04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #[0G)2.TC4Q^\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M:L,P#(=?9?B>R(G9*";-I66G#08K;.QF;+4UC?]@:R1]^R59FS*V!]C1TL^?
M/H$:':4."5]2B)C(8KX;7.>SU''-CD11 F1]1*=R.2;\V-R'Y!2-SW2 J/1)
M'1!JSA_ (2FC2,$$+.)"9&UCM-0)%85TP1N]X.-GZF:8T8 =.O24H2HK8.TT
M,9Z'KH$;8((1)I>_"V@6XES]$SMW@%V20[9+JN_[LA=S;MRA@O?GI]=YW<+Z
M3,IK'']E*^D<<<VND]_$9KM[9&W-ZZK@HJA6.[Z2M9#WXF-R_>%W$W;!V+W]
MQ\97P;:!7W?1?@%02P,$%     @ ^T)R4IE<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M:C&H-UO58UB7I6J//X7W*+F?&^[_$L4/4$L#!!0    ( /M"<E*7BKL<P
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M3AI_YHOA/UY_ 5!+ 0(4 Q0    ( /M"<E('04UB@0   +$    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ ^T)R4CM(
MU,?O    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ ^T)R4IE<G",0!@  G"<  !,              ( !S0$
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #[0G)2#.2?N#\$  !3
M$   &               @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ ^T)R4H.II0/4 0  ,@8   T              ( !@PP
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #[0G)2EXJ[',     3 @  "P
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52P4&      D "0 ^ @  !A,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10021910_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tronox.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc10021910_8k.htm">brhc10021910_8k.htm</File>
    <File>brhc10021910_ex10-1.htm</File>
    <File>brhc10021910_ex10-2.htm</File>
    <File>brhc10021910_ex10-3.htm</File>
    <File>brhc10021910_ex99-1.htm</File>
    <File>trox-20210318.xsd</File>
    <File>trox-20210318_lab.xml</File>
    <File>trox-20210318_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10021910_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "brhc10021910_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "trox-20210318_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "trox-20210318_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "trox-20210318.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "trox",
   "nsuri": "http://tronox.com/20210318",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10021910_8k.htm",
      "contextRef": "c20210318to20210318",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://tronox.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10021910_8k.htm",
      "contextRef": "c20210318to20210318",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://tronox.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001140361-21-008995-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-21-008995-xbrl.zip
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M<)>QK?(U*I2/6UDXGD1 0A]V9\>0T[7G$%^SI$C%-V%"[97;$1#HW$[9C@O
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MA@SJ&YBW:1(/68(JKHKH"-4#,"[D61S\5\> D%"3F2#[W+%*#UN$P?WKJ18
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M/%+PK#1+%6SV^8%9^0VA8G9KKO270B_"A[8>=:TW.LF2J'UP3WYZ]?DBGL2
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M]; $+HC;(!52H% B,DHR0*MK4 Z+9["[FVP/,2MB(QL)) (^ :I<;F6;\UV
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M31U.#FC3$U47 !1;#VF6[KDO',,!$T E4V1Z<-$RR@0*#C19+C\):V?5=?F
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MJ6!_+QZ-^?4-&4+XF!B"+T>1*Z!+!S/N+ME)H75 *C4PX6-@#(@<I&-D?FU
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M';G+82.0.%2''PCN^!:QVS;B?AOL=9C"DE/312/2E@,6H-E@/D6-$P6W4\/
M<XD/FN<QM6_R7=4-11# -=$+224V+J#H'6Q.I9%$".B8DO9'.\%)UW$ 3WMF
M0VJD))U![O7VN%*^RQ8;-.MM@JIEZE!N5OQ62VG_^.J%[<]V0^ 8.'3!J ,X
MX:YP[3LCQ6G=I,KK6*+5W %0NDDW-N8K=&D@J*T*V_2!LKI'.3\V(::I F.V
MM&V9X)H9: W5+!=52)UTR1W&(LIGJ3=1*TQG*#RDU'C;.8V#GVN@4%_+^BP
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MH?+&>CNFMV'^!#9#NU2I<;;6&3];%3-=J>SUC[8/\QK0Z1[57@*4?;A;A='
M5CQ5MT3%[!XX/+=] A #B[JE;HEZ/5%OIDWR!H<[>8:WB^R3<\R9U%71S%.T
MZ=5F'*)V7(87&949<FL,;,JHO4AVBJQGGOKC,?5KVA$OTX??SETTSBYJCQ!S
M>?_K'*G]=2[32_'FS7MG%;=>A]70*?I$HX;.Y9LL6NM"Q]H$DX+6B\[&HNNS
M-FMQ$:.9V<$8;K*'3KB4D>M.;S1,U>H57V]R?.8U_\0[KK*D@JWD."&Z0[_3
MR6YN]Y2EZM:Y9B#'MC)PFTZATRD.M^D47YQ.L;&ZO/ZM>B)O1'JT.:S'5[K#
MQ,Q[33,4S6B1'7)Z:-.)NH+QHK%;5-2CT)CYJ/JX*7#+K-JM8M)23,8/T]IH
M!9TYF23*>8J"SNEM9?1B&K&9VE8$.L,XJ E:6P^(CF_\H];^LS7L2T]$MVTO
MM2^<)3W@6J4GGR-.ZESXTI_@H#N%VJ',9N(SC6V88:)*JBAO7:>RUY232,ZP
MVU[@6BK9T++N=\31P$(E4]L6 $3_CIVC2(#398EZ'!_-M=CM;#'!">UVK6T_
MJU_ ,><>1[6P8N>0;([H+,QN5GK)_'"@AP->7!!S!C!N;/+QZQVD.\YP0I_Q
M&KT_.Z><6I:2=:EO8$[4'IVQ-7#6\I&3!\]'EE@@MM+)*^O$?CE[:"_L#/JZ
MG,5OH-0FBO:XOA!P$V/TMC](6Q6'GS#1.RRQILAOA4,,A+VW_C0H3>$!9;*!
M&*6R;VQ<CY]A??\-YG@.)ME;50%,O/!]HY.W33'X1Y9P!<4\"0,Q.!K"#S@C
M-1<_)U?1?B ^5C'8!WW0L *,7,Z VT2!>/%)](Y.>GTJ(R.UBV3VBLT&C5XP
M3,:M+<ZJ0M= UIH.^:[Y>EG=F1XF;,^P_EK?8Q4M.59DBJ2@;HE\_;3J!Y^A
M5FN3C;(D5U?992NXK05U@?6/8N=X%Z@UP1X$.2/%-$L2LJH[4:X[0]?O%/ !
M7JI]@N]IVH(I$ U<EP :A."U,U]1:WNSK$L'A-5YIK55U\I8W.PC3+UR?E"
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M,VK =?;#?3POJKDYE"N<7AW*Q!P,'1*PQV<BB5.U9VBP7P-R@5.IB:/UGQ_
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M5:U;P,B_88#\&[DX-NW58!CARAO^C288[NCN&*YT=]R$6:VW2C;AP6C[29H
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MMPR.HCNS;BVN2-R,BP!+>]6?%:K/NE&!<8:8NF/TBMMZ8FQ".J."8&75[ ;
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MG]BX1\$ %)RGRNC\X45&$3]X#_R57:>FC6]@6ELW1K\[_JV;@^L%F$$XZY:
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M,]OS@TD6+>C#13E+X,/_ U!+ P04    " #[0G)2OA#I79%&  ##>P$ %P
M &)R:&,Q,# R,3DQ,%]E>#$P+3(N:'1M[7UK<]M&EO;WK=K_@->SLTM540Y)
MW>V95"FRDG@W$[MLSV3SL0DT1,0@P,5%$O/KWW/K&P#J9CFQ);EV)Q(%-KI/
M=Y_[><[?%LTR__;?_RV*_K;0*J&?X.<F:W+][=^^X?_*A_]O>SOZ*8MU4>LD
M:LH7T7=5J9(J2\YT]'U6J"+.5!Z]+_.VR<JB'D>OBYB_2O]>E7&[U$43Q956
M#0S1UEEQ%IV^^N'X79KE\',=O7WW!G[4T<'SG>>SYQ/OVR?E:EUE9XLFFAX=
M[47;T6PRF_HSV-[F97PCZ_C;O$S6T?PL+O.R^ONSOZ3T[UE4-^M<__U96A;-
M=JJ66;Y^$?W7AVRIZ^AG?1&]*Y>J^*^7$?V]SG[7+Z+I9-6\C!I]V6RK/#LK
M7D2Y3N$3&OE%])<)_7OYC-^/7PQ>X@WR[%N8'W[(CR;9N:'MHHJ*LEZH!+XE
M/SR+Z&U_?P84;W1E9[[02(87T>[JLC>':*[BCV=5V1;)=O=/_@)XR)?14E5G
M6;&-ZWD1J;8I[4<5OX0_FY=5HF&LHBRTK#.8/O]B)NB_B(:QTZS.YJ/).,+_
MVQ(2WV8+Z(,+6?Z\S!,DZ.GE(IMG<"PFSV=_FU=N1M]\&?.[_9S,YGR^29V\
MV3[Y\?7I]]'I_YZ>_//#ZW^=1F^^__[UR>F[+V6&I_]X^].;7_]Q^O.'Z/B'
M=Z>G^-/FN?7OV>VISG>:/LF*!!;X(MK9Q^F%%V+G.7UX+RM_]NV'159'FW<C
M&B)#-&H6.OK/OQS.9I.7?7:S^?U E?;;X[-*:V3#?_NF_5:8$8TU?;GEV"W,
MBK88N'16-&6DZJA,HP9G.SUL%E&BUOC!/U05+Y@3?]*D3M-4QTUVKJ-7(!D&
M9A;-UY$JDFBNFPNMB^A#51;E9?0C'!:2&ZL\AAF49QIF4447&4PQ:^JH;N-8
MUW59U?1M5=>PU2"8/F6N)^5RI8KUP"3'])+_+A=%].HY?Z?$SX"$<.:RI 7I
M^&EDNM1QBV3JOSPJJSL/NR[;@=4\?X#7[9<?3]^='K\?1[#D2%4ZBMNJ@G?G
MZT@O5WFYUGA(Z'B\QN.?+4'OV#Y99#J-+/&C-VD*6E#%-T)'<B"B55O5K0+2
MXWUQ5^DGW<!(T?%J5<)5(@4H(?7GE8[U<@Y_FAV,\0Y-^(P6T3$\E.!,X-=W
MNF[HZ5.:'WW=7N'>0#LXT'0W&@&]<KY1L+1/.7)OJPQ.UM#+!X[,2YSR@S\V
ML"O^MB>ZSN DP:;#-B]!#6XT_7TSY7B(DCDL\U?DK.[(N"?A3[5NHK)M:$Q\
M [.RN 2>0FHVS+>B/\)'35:T<""T>VFE<T6/+;*5Y9X#RWB(M_WG-[^,HP^X
M=]^_>7<Z!DHCC>H,5%FBB;G R[9!UAR7YQJ,F$9DA=F#FG8 B PR!82+AE'P
M[TCUDJ3-65DF;N_P;^<J;]4\U^'K6.Q4<%FS%9^!ND5.DNDB)FEZL<AB?@=*
M.SA3H,L7Y46NP;Q)^-LK5349+!P?0C:#DT2.E<)]+R_J%W_.+L)85UD]UV[=
MT'X_^W;Z7-C+-2;5?_YENC]Y>9/_C<+_W(89;ICCK?GI^P9VL*OE/)<)_5JV
M8 ;"-U9E39>;-1F?V\!> \.)JVQ.JAFK9(Y?7&1Y#M<\TE:A,IJ;CD(ERQ+7
M_.?A')S90SPX;W,5:]Q*)U$&3M"KMD*?RAH/DB<%?-4D/#$LTY:@SB\52"+X
M?_[R2E=U60!7K#1RL +>K8!I17D96]Y)#Y87P%47988/ $N[**N/45J52]2]
M%_;Q\:UH1@M>527HS#KQ5@ES5\T+6>HHV[)JW IF28*U\2\+JB73@Y<U;$&U
M*BL4S.@;^K\6KB L;^QI?S1/5+F:Z$VA([BE2V#P2014_UV!4K6_ R8'6!+
M[K\KVUR?JPHXLGEL#&\L"KQ<H"%&D_VC26@/G9CW>_XL^/>C-YG AO@&9,N&
MI92D>]9X]9%@OR*Y3[)F';SOYU]/1$GUAJV!LZ QI*HU&@LJ.<]J$E*HB1C6
MD.,Y*-09;Z8FE9?5F3EZZ^#K':V75#[8"]B,NIW_!J/@>""F0#2IU2+:F?()
MFVL%[\SI/*U0*LZS'*<-Y N)8@]>5L3E$MZM+GFYL9#8<,5-QS31<5:CQO.
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M(K#'<4%+;1O2@R@-@;2@<81175#?QQ%N*_[WG#*1QO!0BB^KVXK44!BX$]#
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MR&.".@&)]7/.W9>A026PGA6T^3$<,;A\^Y2-T9F,6]]P="$%:Q32O*T3)(Q
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MK"#GH'.,E7$K"#;U(.V\>FO3^21#E8*.= <UANBL.D>E?_K#^9NC),W($&F
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MSJL)%\X82U2$EG/T$W@AMT?+<C8K4/E(EB!.6+GG @Y5S3/X-?<*>:ZO2TG
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M!K@ZZ",9&K"Q%975!_8263_<#M':=I7>QOEAT*X(3G&G.*=/ %.MXQL<)F\
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M=_$NFV:@E_OKOV(Y\)\RIF!.N./W.VGRD>*?\U+ZG;@9N.-@<,*X!8&YX/B
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MIV8H&>=S4'J]253'9H4(<G%5OME55YWL'Y> '^#W7S4FZ3CN_34#L7>@8=S
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MST\M$ %L]!K6%HL_ N<-!C/S)?AEA5:5#LVG3W*@_/3F]'0HG84&546!X<6
M2K6WUMY2/BUQY81?-WP G&<'713]1ZU##7:7G,,8[8QCL#D4N@JZX2CKEA:O
M$'RK*O%L5"C#8W00T5?8/:.3-G:Z&.D%)K$'+7FQL+.*742YNGS 3.?P03(=
ME$EW%Y6RSEW8H$PB%>PB@4N%/HVE2$&C__;/I9SPEP4F,^+W7H.A$.W<^FZ]
M?#UTS6TJ0)W!UU4ETUKCNU12KAOGF Y\-<@VHAUXZ%/O>H?N=F*4JV"8;*.J
M<XU3*?E3RY: \L"V V:-OH:0_QK]88!G[,!RZ(8OLW.D@KP/O74H+=*LCN$;
M&XH 6:=?HCE=QI&&J-%CAKN?QIG?T:*W4DCX$_I//V2K=A7Y%(W*-3KDVZ+G
MR09BM&N<X13H9.2(_RI*-M$*#20@U(B8?\)./J*B!/F&CBQ8X2HKV,)CHQ0>
M7(%R&97D_<53#%IOBAP7>7(,!IFN,A5I4$<7>58O0T.M>_"0S,S^A\1Y%5"
MW)\4FR!_><=.HQWES!.C!--'0!?1L/%0!!2E="1=&P=MK7"C2:VE1U^^YJNC
M61RL54:^5KE68$S66=.2MFK#*5V'A/54IRX?B[-U3E5;BVP-YA28K@DR('HI
M,AY5X?F$PYSE]+V$%)N.O<YK!9L$[A'-.(Q!/6 A=O2P_6L_E\7Y'IJTGOSP
M5<G/).DLJP9CCIE"CA/#TTU.*JO9;A6#X7G].P7X:5YGH&XUFXYX?,IY2.H<
MYGB.!YX2OY$848<8GR9,?WXW+$UIF7XXCBU]N&/T%[ADXE\+R'JMT6_,_9 8
M_S$=3=DN,<OV:6WV9:42+2_ILRYRLK'\W\J5[&["9QD8X;!T60T'H+/.NU!P
M(]-:6;<E97X:&9VJB[+BY V4UMYP=JI;)A2N_F-9U&-,Z&8Q(0Z1!*\8J*PQ
MI.A_\S9E?4>]*ALVRLQ#.*#][,EW>]$TVANJ9-I.LH<=Y+H7$O7X84M4YLP:
MM%%=Z#1KMJ7U6->L+Q!=R(3Y(SRAS7@+'H],+@E7514F+E &MR=,0!5O&U+V
M*'&$5+U1A'%XL%%&$6XP_O>"4LA&\%"*+ZO;BG1M&+@3J\$<.LYD<T_)9/KS
MH _FX\G.^UV:Z<CX/8AIJPL%6BXNMI/$!&O'T<3$[*03U;WLF<$B ?RN+M.G
MG0R.4O(D&HH8K=<YD %FT-%*"JJ;1E)U<O7"'1FR9D#A-QFC(+9!1JW(_!2S
MDT1G-BC72G%]D_JSD<7;%\)L=TP:1UF1I-05V;N<6<2O>L"J]V3\&3C%G\$B
M_JGB;<KUOX;/)!M=%_(].OC+,L\HUA(JWN9NA+J9/:MVB#5\/=YXS@HTYBE<
M,^2L188"#\ 9UA=X'O$D]P+:192B^G>I]7L.60=S!GL^ OZCBP3,9[2AOP*-
M[,^_0G=?8'(_KI #KSC!B']9;4R"R)"\[7N"V+P2$4#>L;K),%V0PHT3B3:2
MG40IJI>4H$D5:#79IS8K.[4S468FZ/52'S!C'^.3=/HE+>(A1_LG=U.3<O_.
MVO<FM'WV 1T1UR9J5SI;+=JJ%I\<*G%EV^R5Z=ZZC-_KQL;*03FIU(4&70Q,
M!?@#Z6YD-UGW*)G&@=]=RR0B+_\$5#]4%!*CH?B^TS+M>#31 V!RBPN8+^BA
M:=>4=QY/*3OA4[S@<"@\;%^.;LT%)@DTF<V)(/W$S/,AG_C/4:/P9^>X4'"9
M$J3Q=)W"MZLR]V_ '[*_#=>6ZCROUPISMO[V9/R$?E^C:B^_H_G^^_1P?C#3
M1\E$3X[FBX-X<3@^3*?SH\ET#):V.H2OY:JNV=#_.:N;=SCV[5&% BO^AA!#
M_"_0'9I0E\!/$C,G><7AU)[-*Y!:F'I-<NUP7(U\H=&^4+F9=5.N[ZP:63V]
MT408H6AP(CUZ/NF,%IZIKB_D8Z:\#4WG(_A"[[(@OS\!_LGU$]XMN89!A EB
M8889,NPN#?"?YWOOE=":N"2S:<_4-3[:M>)OF@?;@K3U@<@GIIRVYTLO-I3Z
M,WQ.7P^"31)20IM!AJ7Y81F-F/ JD%#P<U8F(/C($XZ+KE#LQ-KDG0VM?G J
M5O)VUN9)9)NG9N6H%9[7KK1+-!7'56M7VN+PUMPA^XEJ>;*8$Y&-4XH\)J@3
MD%B_X&H+&1I4 NM909L?(RV#R[=/V4"D22;V#4<7+;%&(<W;.D'"X(KGQ\&W
MRSM )>$0BIU0X(KBW1*W1V4".+U4W;N#ZS@1J@_XUSR0ET&?[R"KA ^J 28-
M'R.% E'VW7708X\N^)X+?O;H@K^M8G,TCF?J<*[U<3K7L\.C6(&B$Z='\V.E
MQW/]J-A\-L5F\;4K-K^"!$>$'DHP0?;^AFH#G=;CEXV^-B47ZDK+X88ZT=F'
M6".8C!<4-V:NS?[VRPP7&DQ74]187:DFH7O>)=!<=M>((G6X,I:2A4R,P3A>
MNX)I2T)Q%PV __4\4IQO+V;X,X2"V#G9I4P)F[20P)^5S44#*0TJF"DOKDK,
M1$6)O_-A-YH^'4>K-F\R6YV\L]GE&'^[HH=>[F[-?7.>89_,MJZ&OM;16<,2
M'DKNCSF6,>"1X'_^ >+"&WV!T%&UI-QA. F4RYV7+W<'4M&\7%Y*FL0Y$SVR
MHFY V^+85'DAZM!T'JW@P"V-[NDO+,SV&E $PP4^CW:^W^UHGCN2?HA2:P]=
M@10*H@(%TOP&"<!@#Y5>9>V*$:\$[<IFVRRURAM,MT.(-UR+ ;%@QZ1\8+(8
M3?DSK/MR64;V2]K6#I..:AX/%EC)N1=@$Z='>JHCG5A"H7#>HZ*FJ 3>IE>K
M(@-E._J^37"?WFA839SEV4 U&/\[X>,Z.3[:CW9.7WW_!HX[:=I] X$">JJ"
MLVP+A!/&).-8&XEQ3:4I1[N\TS7OQO8]#99L3JTDPWDJ]D(39(<?M%TXPDI4
MT]\H#M>2YEWVBV_XG\1XJ]LG&A&]B,?"@>D&EQQVW<[I+M*S*O<JU< /B,7@
M =T$9IS!7/-S6S./%)TC@_>[EB10//XQ 8X!38'M\&#D%L1AADBP$R;+"K/:
MF&LH/,XX%SGYF*=R6;9Y0GF-K7:3;O,\F#G"C8'YPH7YS)F+=H6P967E@,FR
MVOQ%ZNTIPI88&(*0&)T39 L1<=>W@G7P;1VT:+4  70F-#O8WW4,KI>:99))
M PH'J:5;@NIW"J_Q&H[4&SQ26_.T P-P=.L7O46I0&Z#UV(R#[W, O;T/ _D
M#Q"CF^W:/3ZSF4WY4QCLH9P#K-ZA7R1;P\ /RJT_QUOO97<'D5>?4U*2/)K]
M.-C0WELD/F&UO/DP#.@-6!Q+5K5.[JA0%T]J-S&"%BL+(,F#2A=G;G!B":M=
M5+E'Z0=B^M.2W/SY9B6@_Q22E0'D,!!1J%<98-=>F@G_DT<]9<!\H8=0R%N"
M9-Z83!!4,(.\;X<IM0"&K8RVMD+4COY)PMMF\TF"7'9M <GQ30EP?_BN!2)Y
MHW,L<XIV"+DN)1YFT%+ZL4>I0W8^N)UAC3!0*7;-NP9F?3!F-G4CQ:6C$]\A
M:)G3"+D4RE9\&O)@G;41G[8P-!O4!;KU6.3IPL/)]$RSJFXL_8BJ<DBI:*:)
MEWOMVOZ=A'-'D##&+$D.JALG'GF9U>C;T@6S3H_MBP9BP$5]^EZC_AKU+)PR
M?1G=ACUL,/[G,1 ?VL5Y1:E8'<@SLB]8@++.VC7]&NB]-ZQXJT'G3EH,Z77N
M&J54$;.XD)H-T3 5JM!FV\WB8'02OUM/;& 8#2T_J VNJ.I#(-I /5; 6H "
MXEKNC_[H_+L_SK_YH_/OELZ_=!(OCN;)\6)V>#0_/#I4^X=I,AX?CZ>'Q^/Y
M0?+H_/MLSK_X:W?^_6 5BSMQZ+U,1P(B-BCZT*CQ1.\Q:3=& EL).$+EL^O&
ML1K0:&BFH_OG$!ST!)*/\ ]V",[^;(?@T,H#'^$=.00]X/!H9[*+;N&&P>7"
MPX'CJKQ&G[78(+%]1"P+UGZ,/8('8-U6Z[)F4_JT3%#78=2^^?CX9.3KFP:+
M$9@VGB79/-'+AD]!Q@97A"VW8"%YNUK3YACD%1C\8+SGW8T!_;][X'4!MBS6
M,@,9L$JU&@6Z+"GN/=)0\??.] K:63@GA$IJL@8!=6])QR%:? )I+1T_JS>X
M[XUCUQL.$7I*[LHM<OKR=$ 5OLHUPD2ZK7<D*,B &<EC^%5BOS;A)(S,D/&'
MQL'&)#YDQ<AD1 RRA#5[$=@B&!@,+/,J%I1G=%R@\Q\]84L%Z[*GP/\B&#>4
M'(%87: W51G88;J7HS)R)9G&'T24^_ZNJ.9EP/#30\OOTQ,_L40+J=.GR.@*
MD@R3 <MU@,E0YJ>7HJ,,M *H+W!0:]^[A10(204F=<)VM(J7&7P!Z(82JDIR
M0=<6[[#WBMU!I_#=70XI _XG$W0K7,P-_$;#5\T7V<0D>^^\A7=IFVM /"HP
MY;"X"0ZBY.IP&HYS*UKX#O>1[\SPW=-XU)!3@YU=^T$>%8.A0GT^A!G*X22D
MB/#XFW- 2QS0Q!A.0Q*:D9>2B+E=WEN@H*D@B-.-2S..,-:B(=3$<"'6\-Z1
MP"F"58?A+TYY]FD_0'&Z>NPTOBN_8->-ZZ,+]<3F%^=$W);X=R._XA?N1+SF
MZ%_O5_S2G8A#!/#]BL-\^ J0P:L=B</#T:1MV1L/QV%@(QJX/J_6^KW!(PA-
M'109KKI3@,'A=EYRW\$5B(/S8'_X<-5;3$.?87&LB 8W6QN&Y$,4CH*5@#SO
M1%2IRYN0';>*AZ5"%C 9F9?@,T&NJ$GRW3B8=X[U=JP]BKMBB0C">Z,%(J'N
M$7 LRNL1_F5*E9F/79$AT\\F[FO;CR[@^^,"WG]T =^_PJ7/@1K^9Q0N_5)B
MNB!*X'?J0_1C5=;UWC_6SZ/7\ .EZ[PQ (THOEZK"@P4=%8,&,S;<'"YK (-
M)@%Z# !I\:^V<Z8)D;NT>@,VULN\L9(G9%9.JFV3=ET]=<#ND&H% R]@8MTL
MC$'?:"L2^ %[M\Q61,T. KV-G%/GXQ-$5+>?E_5(.*=1;89?FYWI@C'PY(WO
MR'.%K;0JQ!@Q*N_T:/RC2W)A .61IQUE-0LF20FR>40=K G-!PK3^+(5NJE(
MZEF]^OCX.'C))[;"-8=W$,@/C9"!:DZKQ'=5-)W1GMN ;&71(W)N]"5* (AO
M7CV+\)')E5/OR6ZEMLF@ZK'.&Z2VI!I;/^:CB#4KU",1#*/3VLJHEVYYY"_G
M'C32+'(P9=)0%I08]%:&:W<:C-/63NAV>G><7&Z&/EVHA+XJ[,&RD"F!-;RD
M82]D7+E0&O65@FWA86? M@NKZ@"$1$A37/4"(AW=Z9  W@4?,EF'AZ83$9;]
M4#=J#E$\C=[B\:@<CJTE"/Q'.L@!<X@H?]"8,J*R.@/;NT*^ =J]C?TOHA-Y
M^Y>[D!,\$N^ZR1_D-5D[V.L;(#?=K<C D'5@)+L^(-=)"%'N0.N/S6T@-+)/
MZV+N!AJ&[EP"P^FL;1CE#5.VI%4&;6C&XLIXF7H]?4UINO&]/XU^Z$0T5GS]
M*;E8Y7$K778#'X-/V)$)>EG2<,_%]]HO%R?_XMIA)%,SI _92@:GS+.*6+GO
M8[1L!(>LT(W;32)VKQA1N]HH563THPX,][SICS]@'\MYJUEV$)11A[^'CAOC
M+^,M25L8N%YZX3]+"6*Z64'>3N?I*^-60)/J0=IY)?ZF/5*&*@4=Z0Y0$=%9
M=8Y*__2'\S='21H7(K@%DSG5+D'4G]5 DT(R#?WS@<Y#-/-4TS\CV(O*P^ E
MP!A&L7$U(RY@5%X6NL*VS@-6?4<S<-%2<GJOD0A-;_KH8/"?Y 7@ROT%< NV
MM>U4)]MD.$MNC'Y.=>SXQD(Y=YU7N=[.H.JVND#R7!U.?<CP"G??/^1^6"DO
M@7:K(DNSK3!0+UU'-A)2I*^2#E18Y%X&5".\,,)/XU()#SU,S!&.M8R\ 4;1
MFFLI.#X$AS,GT&R3'!_G*EN-)*(1:]:0Q%'4;-9Z-"2'?8:2R0(WB#:7:E2[
M!;(JD58]U8J9 %\BU$Z1N9DX!O=6_)VC4WR5A9=X,B%7ER/\B)I?8M8-T9-,
MF9>%:8=+ZR%YR ]^O]G[65VR&L8)%=+1Q-1.JQ5*^L&.!;V490^^560! ?:9
MPO(=#Y'/1"K(S66FE5R@;FC=N<8'AY1NFK(J]*86ED'\>%?4ZYJQH[.:MJ5E
M#.V*&1/)M=+X!!F'FV-M+.[U.>\S4*!<937Y"D=1H<_A@G/B!?LH+Z2#4TT*
MQ655%N<)-7[91@$2IMZ"D$D90N"64Y5]!YHO(,I CYD!3VXW*28+KQ(^T @7
M==[1FG&8M.TUV/V6"]&0RXPBMUA8CV_P"B8&H!&WM"J]#LW6-Z^=;6Z^W>NC
MRD%:?A?H:=S%QP"6BV\:20)Z#@(LLBV%JA>AIF-N2]WJK;*;8G)@J-1X7;-Z
MC0X1Y O(!4P/$SAMJ!!T.Y9X)T_70\C/GN?;CT7Z2 /&B!A04J_/V!J92JVP
M$H> (+V@77B*; 2-71NBQ!G @SB#U>)MLS /<K%).^J8H-1!NG??!Z[[MBMM
MT2?$D[Y35L'M[<QI8 ])M;QR$SO7+AD&\.XEPU$'DV6&!2PE=<V#DY1G@@4:
MTD%_R%!SW!G"">037V<?J#))8#K)SM\-K[BL'-:#O5)9&QQ@ 6T%"F*MQ1K@
MANZ44$B@&9>%V9"1NYZ&Y)0S(:V)S6=V11ZZ*5]/))*MJA0_F+W8GL4:DF+H
MNI,)94;R[SY?#<=&_ ER4MDC>/57&SDY>(R<W#^;Y.X[J=T/F^2T+-(L$2[_
MTCDJGD>_8B?5UYP^?)]PW^+I['B6'.U/XF0RG^VKXZ/]Z7A_NDB.CM)Y<O"(
M^_:(^_:'5DB\L$6N+*F'[\_'ET><U%%;&Y"3;# /Q%.P;YT3>?U\391-LJ)J
M@8&N>]#RQB] 5E"%;HD:NQAZ.7">YQ-]VMJ$I9:J0IFPWG#( [0@L#2S..*G
MQ3NQ:@NR[ <S9$'-RC$WU+=^*9/)X+QU+#-7I1^3%QO?P9V#8_%J&QBX*ZT.
MVWD8D\\N5-Y*>R?ZS']?(OF(FH)"#;I@:LFM\IS!Y#1U^V&F@!HM 76#[C\:
M6CWY9T"?9^/T&_+82%O"IUN/)&ZAV[Y@(@ZLOHG.P?(@XD;O"U2KN87R6C<9
M6[Q5\+2!Y.'X2%*B9F[7D:O+M,TI1GO5O+RNT)R'YTUM.!56-H#2[2[*'-V\
M%9QZM(#BG$*U)M+'\^J@,>Q(#M(EFB12URX+X $P-&Y?8,)%J%AA7^<4W>UM
ML^'@N5L3V!*[SP.R6@*RD2Z>;@XLVOAGRKZ76/QBW8C!$ $R8UJ0,=M/S.P=
MW.<< ^YLN%VA%^E"(F*J=[E&AQ$&*RQ)%VQU5ZCQ<2Z_H$I:(U9:7G_DY,CG
MACD&P/:P<3<Y-A&Z!L_%T/+QJ)27NG,S._'5;5O42R/K$AQ#H4$B@.>9TA\4
M.DWKJSB_.<7#SK]^-9<T$LR1T>9D3AOV.;SU[D4^[XO;&FP@,!^?,P!&419[
M=*:I9QZ</=L W0&7]^)2JE'T=?A^W:#G[#R+/9!JZ41=@^K>B6I=X_&T3)E
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MLA29!'IJF81T0LME/,LD-6#TW[7T+*!G*H1FXKX\'6R0?RM_'T8JOS>'WZ\
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MP$^^-;Z=#-A"U@6[+^_BFX50)1+$V]=6\U0@=A6' (1I05KSV-XZ7H),ZBU
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M<V/ZOXY8R*PN2,OHL=>R$O [?F*Q_=E^8O'E%\=/Z&<L_B+^4N=_4$L#!!0
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M?O(_J<O_9'_^)U7\3_K!_[0F_].:_$\/PO_TT/Q/OY'_:1W^V;+U= >8UJV
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MKN[A$G%.&;T%J2YY'40LDAGBGN 65!KT-F<0<@]:(O<DBS!98U*09!\U*;S
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MW; 3_ OR^PC_P;]0_N4_4$L! A0#%     @ ^T)R4FW01J0S'P  H;,  !,
M             ( !     &)R:&,Q,# R,3DQ,%\X:RYH=&U02P$"% ,4
M" #[0G)229_HAV$R   W)@$ %P              @ %D'P  8G)H8S$P,#(Q
M.3$P7V5X,3 M,2YH=&U02P$"% ,4    " #[0G)2OA#I79%&  ##>P$ %P
M            @ 'Z40  8G)H8S$P,#(Q.3$P7V5X,3 M,BYH=&U02P$"% ,4
M    " #[0G)2]MA\R*]'   :BP$ %P              @ ' F   8G)H8S$P
M,#(Q.3$P7V5X,3 M,RYH=&U02P$"% ,4    " #[0G)2F^NOL;L+  "R(P
M%P              @ &DX   8G)H8S$P,#(Q.3$P7V5X.3DM,2YH=&U02P$"
M% ,4    " #[0G)2AC/6DVT#  !^$   $0              @ &4[   =')O
M>"TR,#(Q,#,Q."YX<V102P$"% ,4    " #[0G)2NZ)M_YX(   @60  %0
M            @ $P\   =')O>"TR,#(Q,#,Q.%]L86(N>&UL4$L! A0#%
M  @ ^T)R4B [J5CJ!0  F3\  !4              ( ! ?D  '1R;W@M,C R
C,3 S,3A?<')E+GAM;%!+!08     "  ( !H"   >_P     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
